Page last updated: 2024-08-22

cladribine and Hairy Cell Leukemia

cladribine has been researched along with Hairy Cell Leukemia in 377 studies

Research

Studies (377)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.27)	18.7374
1990's	145 (38.46)	18.2507
2000's	121 (32.10)	29.6817
2010's	91 (24.14)	24.3611
2020's	19 (5.04)	2.80

Authors

Authors	Studies
Arons, E; Braylan, RC; Calvo, KR; Chihara, D; Dulau-Florea, A; Feurtado, J; James-Echenique, L; Kreitman, RJ; Maric, I; Patel, KP; Raffeld, M; Steinberg, SM; Stetler-Stevenson, M; Tai, CH; Wang, HW; Xi, L; Yuan, C; Zhou, H	1
Herbaux, C; Montes, L	1
Cui, HH; Jin, LF; Shen, WZ; Zhao, HL; Zhao, M	1
Hirata, H; Io, K; Kitagawa, T; Nagai, K; Oka, T	1
Bhangoo, MS; Burian, C; Cheng, B; Hermel, DJ; Saven, A; Waalen, J	1
Maitre, E; Paillassa, J; Troussard, X	1
Argnani, L; Broccoli, A; Catovsky, D; Cross, M; Dearden, C; Else, M; Janus, A; Maitre, E; Robak, T; Troussard, X; Zinzani, PL	1
Anastasia, A; Annibali, O; Broccoli, A; Cantonetti, M; Casadei, B; Criscuolo, M; De Luca, ML; Deodato, M; Falini, B; Fianchi, L; Frustaci, A; Galli, E; Guarnera, L; Kovalchuk, S; Marchesi, F; Motta, M; Nizzoli, ME; Offidani, M; Olivieri, A; Orsucci, L; Pagano, L; Piciocchi, A; Pulsoni, A; Sarlo, C; Simonetti, E; Spolzino, A; Stelitano, C; Storti, S; Tiacci, E; Trentin, L; Varettoni, M; Vassallo, F; Visentin, A; Volpetti, S; Zinzani, PL	1
Haynes, J; Jackson, M; Smugar, SS	1
Dehghani, M; Haghighat, S; Karimi, M; Kashkooe, A; Majidi, R; Namdari, N; Rezvani, A; Safari, N	1
Arons, E; Burbelo, PD; Cohen, JI; Eager, H; Feurtado, J; Gould, M; James, L; Kreitman, RJ; Mauter, J; Ortiz, OS; Wang, HW; Yu, T; Yuan, CM; Zhou, H	1
Argnani, L; Bagnato, G; Broccoli, A; Carella, M; Casadei, B; Coppola, PE; Gugliotta, G; Nanni, L; Pellegrini, C; Stefoni, V; Zinzani, PL	1
Cornet, E; Maitre, E; Troussard, X	1
Ramos Perez, J; Ravandi-Kashani, F	1
Boubaya, M; Cornet, E; Damaj, G; Decaudin, D; Devidas, A; Drenou, B; Dupuis, J; Eisenmann, JC; Feugier, P; Ghomari, K; Gutnecht, J; Haiat, S; Hermine, O; Hunault-Berger, M; Huysman, F; Joly, B; Karsenti, JM; Lambotte, O; Lepretre, S; Levy, V; Lippert, E; Mariette, C; Noel, S; Olivrie, A; Paillassa, J; Petitdidier-Lionnet, C; Riou, J; Tanguy-Schmidt, A; Thieblemont, C; Tomowiak, C; Touati, M; Troussard, X; Uribe, MO; Vaillant, W; Validire-Charpy, P; Vaudaux, S	1
Ahn, IE; Calvo, KR; Francischetti, IMB; Kreitman, RJ; Obiorah, IE; Raffeld, M; Wang, HW; Wang, W; Wiestner, A	1
Andres, M; Arn, K; Bargetzi, M; Baumann, M; Benz, R; Berardi, S; Bianchi-Papina, E; Blum, S; Cantoni, N; Chalandon, Y; Feller, A; Hess, U; Hitz, F; Li, Q; Lohri, A; Mey, U; Novak, U; O'Meara Stern, A; Pabst, T; Passweg, J; Rauch, D; Rossi, D; Stussi, G; Zenhaeusern, R	1
De Benedetti, EC; Rivero, CW; Sambeth, J; Trelles, JA	1
Abou Dalle, I; Amhaz, G; Bazarbachi, A; El Cheikh, J; Ibrahim, A; Usta, U	1
Argnani, L; Broccoli, A; Carella, M; Casadei, B; Coppola, PE; Gabrielli, G; Lolli, G; Morigi, A; Nanni, L; Pellegrini, C; Sabattini, E; Stefoni, V; Terragna, C; Zinzani, PL	1
Aguado Lobo, M; Espinosa Lara, P; Jiménez-Reyes, J; Quirós Redondo, V	1
DeKoven, M; Divino, V; Gao, G; Gaughan, A; Karve, S; Knopf, KB; Lanasa, MC	1
Dean, R; Hill, BT; Jagadeesh, D; Kalaycio, M; Madanat, YF; Pohlman, B; Radivoyevitch, T; Rybicki, L; Sekeres, MA; Smith, MR	1
Aymerich, M; Baumann, T; Campo, E; Delgado, J; Giné, E; López-Guillermo, A; Magnano, L; Martínez-Trillos, A; Mozas, P; Ortiz-Maldonado, V; Rivas-Delgado, A; Villamor, N	1
Ar, MC; Aydın, Y; Başlar, Z; Berk, S; Elverdi, T; Eşkazan, AE; Öngören, Ş; Salihoğlu, A; Soysal, T; Tüzüner, N	1
Dahm, AEA; Dybedal, I; Habberstad, AH; Randen, U; Spetalen, S; Tjønnfjord, GE; Tran, HTT	1
Andrasiak, I; Rybka, J; Wrobel, T	1
Andritsos, LA; Grever, MR; Kaffenberger, BH; Kuehn, GJ; Li, D; Wang, RF	1
Aviv, A; Bairey, O; Braester, A; Fineman, R; Goldschmidt, N; Greenbaum, U; Herishanu, Y; Inbar, M; Najib, D; Polliack, A; Rouvio, O; Ruchlemer, R; Shaulov, A; Shvidel, L; Tadmor, T; Yuklea, M	1
Andritsos, LA; Grever, MR; Kaffenberger, BH; Kuehn, GJ; Wang, RF	1
Aviv, A; Bairey, O; Braester, A; Dally, N; Fineman, R; Goldschmidt, N; Greenbaum, U; Herishanu, Y; Inbar, M; Levy, I; Polliack, A; Rouvio, O; Ruchlemer, R; Shaulov, A; Shvidel, L; Tadmor, T; Yuklea, M	1
Amarante, GD; Buccheri, V; da Rosa, LI; da Silva, WF; de Siqueira, IA; Neto, AC; Rego, EM; Rocha, V; Velloso, EDRP	1
Bogdanovic, A; Colovic, N; Gotic, M; Kraguljac-Kurtovic, N; Marisavljevic, D	1
Chua, KYL; Holmes, NE; Meher-Homji, Z; Phillips, EJ; Seymour, JF; Siderov, J; Slavin, MA; Tam, CS; Trubiano, JA	1
Kojima, M; Kuwata, T; Minami, M; Minami, Y; Miyamoto, K; Sugano, M; Terao, T; Yamauchi, N; Yuda, J	1
Cao, H; Goddard, L; Kamal, MO; Liu, LW; Moyers, JT; Ossowski, S	1
Bénardais, K; Gudi, V; Prajeeth, CK; Singh, V; Stangel, M; Voss, EV	1
Acker, T; Andrulis, M; Blume, C; Capper, D; Dietrich, S; Fröhling, S; Garvalov, BK; Glimm, H; Ho, AD; Hüllein, J; Hundemer, M; Jethwa, A; Lehners, N; Mandel, T; Meissner, J; Schulte, C; von Kalle, C; Zenz, T	1
Han, SH; Hur, M; Kim, SY; Moon, HW; Yun, YM	1
Baltasar, P; Carbonell, F; Colado, E; Da Silva, C; Garcia-Marco, JA; Gomis, F; González, M; Jarque, I; López Rubio, M; Loscertales, J; Monteagudo, D; Monzó, E; Orts, MI; Osma, M; Pardal, E; Perez Calvo, C; Pérez Fernández, I; Seri, C; Vargas, M	1
Das, R; Jain, S; Khadwal, A; Kumari, S; Lad, DP; Malhotra, P; Prakash, G; Suri, V; Varma, N; Varma, S	1
Burian, C; Rosenberg, JD; Saven, A; Waalen, J	1
Arons, E; Calvo, KR; Kreitman, RJ; Raffeld, M; Roth, L; Sapolsky, J; Stetler-Stevenson, M; Wilson, W; Zhou, H	1
Grever, MR	2
Audemard, A; Comoz, F; Crochette, R; Ficheux, M; Salaün, V	1
Park, JH; Tallman, MS	1
Attias, D; Ganzel, C; Gatt, M; Goldschmidt, N; Polliack, A; Tadmor, T	1
Brousse, N; Brouzes, C; Delarue, R; Derrieux, C; Emile, JF; Gibault, L; Hermine, O; Kaltenbach, S; Michonneau, D; North, MO; Trinquand, A; Varet, B	1
Benz, R; Kerl, K; Nobbe, S; Urosevic-Maiwald, M	1
Jain, P; Pemmaraju, N; Ravandi, F	1
Beyan, C; Kaptan, K	1
Argnani, L; Broccoli, A; Casadei, B; Gandolfi, L; Maglie, R; Pellegrini, C; Pileri, S; Stefoni, V; Zinzani, PL	1
Coskun, BN; Dalkilic, E; Oksuz, MF; Orucoglu, N; Oztürk Nazlıoğlu, H; Pehlivan, Y; Tufan, AN	1
Delforge, M; Dierickx, D; Janssens, A; Tousseyn, T; Vandenberghe, P; Vergote, V; Verhoef, G; Wolter, P	1
Estrov, Z; Jain, P; Jorgensen, J; Kantarjian, H; Konoplev, S; Luthra, R; Ok, CY; Patel, KP; Ravandi, F	1
Barshack, I; Feldberg, E; Filanovsky, K; Shvidel, L; Ustaev, E; Vorst, E; Yacobi, R	1
Akay, MO; Aydogdu, I; Bilen, Y; Celebi, H; Dogu, MH; Esen, R; Eser, A; Gurkan, E; Hacioglu, S; Kayikci, O; Keskin, A; Korkmaz, S; Kuku, I; Sivgin, S; Tombak, A; Yildirim, R; Yilmaz, M	1
Abdel-Wahab, O; Salam, L	1
Marisavljević, D; Marković, O; Živković, R	1
Aygün, S; Serinsöz, E; Tiftik, EN; Tombak, A	1
Gurram, V; Kaliyaperumal, M; Kreitman, RJ; Lakshman, MK; Martínez Montemayor, MM; Pottabathini, N; Relangi, SS; Satishkumar, S; Sharma, S; Vuram, PK; Yang, L; Zhou, H	1
Dearden, C	1
Andritsos, LA; Grever, MR	1
Catovsky, D; Dearden, CE; Else, M	2
Ravandi, F	2
Kreitman, RJ; Pastan, I	2
Campo, E; Martínez-Trillos, A; Matutes, E	1
Getta, BM; Park, JH; Tallman, MS	1
Chavda, SJ; Dearden, C	1
Brandt, M; Burger, J; Chihara, D; Faderl, S; Ferrajoli, A; Jain, P; Jorgensen, J; Kantarjian, H; Keating, M; Luthra, R; O'Brien, S; Pierce, S; Poku, R; Ravandi, F; Thompson, P	1
Bertele', V; Garattini, S; Gerardi, C; Joppi, R	1
Chavez, JC; Juárez Salcedo, LM; Klippenstein, D; Sandoval-Sus, J; Zhang, L	1
Abdel-Wahab, O; Andritsos, LA; Banerji, V; Barrientos, J; Blachly, JS; Call, TG; Catovsky, D; Dearden, C; Demeter, J; Else, M; Falini, B; Forconi, F; Gozzetti, A; Grever, MR; Ho, AD; Johnston, JB; Jones, J; Juliusson, G; Kraut, E; Kreitman, RJ; Larratt, L; Lauria, F; Lozanski, G; Montserrat, E; Parikh, SA; Park, JH; Polliack, A; Quest, GR; Rai, KR; Ravandi, F; Robak, T; Saven, A; Seymour, JF; Tadmor, T; Tallman, MS; Tam, C; Tiacci, E; Troussard, X; Zent, CS; Zenz, T; Zinzani, PL	1
de Oliveira, JR; Fonseca, SB; Gonçalves, C; Lopes, V	1
Ravandi, F; Thompson, PA	1
Golomb, HM	3
Bargetzi, M; Gratwohl, A; Hess, U; Simcock, M; Tobler, A; Zenhäusern, R	1
Cannon, T; Mobarek, D; Tabbara, IA; Wegge, J	1
Denton, C; Evely, R; Juarez, M; Marshall, R	1
Bargetzi, MJ; Gratwohl, A; Hess, U; Kovacsovic, T; Leoncini, L; Meyer-Monard, S; Rufibach, K; Solenthaler, M; Tobler, A; Von Rohr, A; Zenhäusern, R	1
Austein, T; Schmitt, A	1
Al'-Radi, LS; Diagileva, OA; Kaplanskaia, IB; Naumova, IN; Samoĭlova, RS; Tikhonova, LIu; Varlamova, EIu	1
Hadzi-Pecova, L; Panovska, I; Petrusevska, G; Stojanovik, A	1
Holzman, D	1
Catovsky, D; Dearden, CE; Else, M; Forconi, F; Garcia-Talavera, J; Haynes, A; Johnson, SA; Lauria, F; Matutes, E; O'Connor, NT; Osuji, N; Rohatiner, AZ	1
Fitzgerald, DJ; Kreitman, RJ; Margulies, I; Noel, P; Pastan, I; Stetler-Stevenson, M; Wilson, WH	1
Baraldi, A; Bertoni, F; Cantaffa, R; Cencini, E; Forconi, F; Gallamini, A; Gherlinzoni, F; Gobbi, M; Intermesoli, T; Lauria, F; Leoncini, L; Pileri, SA; Pulsoni, A; Raspadori, D; Rigacci, L; Rinaldi, A; Sabattini, E; Sozzi, E; Stelitano, C; Tassi, M; Zaccaria, A; Zaja, F	1
Bargetzi, M; Heim, D; Hess, U; Leoncini, L; Meyer-Monard, S; Rufener, B; Schmitz, SF; Solenthaler, M; Tobler, A; Zenhäusern, R	1
Barth, J; Rummel, MJ	1
Arons, E; Kreitman, RJ; Stetler-Stevenson, M; Suntum, T	1
Apter, S; Davidson, T; Farfel, Z; Kneller, A; Sahar, N; Schiby, G	1
Imada, K; Onaka, T; Ozumi, N; Yonezawa, A	1
Huynh, E; Saven, A; Sigal, D	1
Fitzgerald, DJ; Kreitman, RJ; Pastan, I	1
Asou, N; Fujiwara, S; Horikawa, K; Ishihara, S; Iyama, K; Mitsuya, H; Miyake, H; Nosaka, K; Yonemura, Y; Yoshida, M	1
Alexandrescu, DT; Dasanu, CA	1
Cremades, S; de Revel, T; Fagot, T; Konopacki, J; Malfuson, JV; Souleau, B	1
Burian, C; Saven, A; Sharpe, R; Sigal, DS	1
Guest, JF; Jackson, G; Sladkevicius, E; Smith, H	1
Kung, AW; Kwong, YL; Lam, C; Leung, R; Lopes, D; Wong, KF	1
Hoffman, MA	1
Bhargava, R; Kar, R; Mahapatra, M; Saxena, R	1
Miller, HJ; Saven, A; Schram, ED; Sigal, DS	1
Helbig, G; Kyrcz-Krzemien, S; Pająk, J; Wieczorkiewicz, A; Woźniczka, K	1
Johnston, JB	1
Tallman, MS	1
Tadmor, T	1
Cencini, E; Forconi, F; Lauria, F	1
Ahmad, H; Catovsky, D; Dearden, CE; Else, M; Forconi, F; Kelly, S; Lauria, F; Liyanage, A; Matutes, E; Ratnayake, V; Shankari, J; Whalley, I	1
Cencini, E; Forconi, F; Lauria, F; Raspadori, D; Sicuranza, A; Sozzi, E	1
Saven, A; Sigal, DS; Torrey, ML	1
Juliusson, G; Samuelsson, H	1
Arons, E; Kreitman, RJ	1
Forconi, F	1
Chen, D; Colgan, JP; Hanson, CA; Ketterling, RP; Viswanatha, DS; Zent, CS	1
Li, JY; Qiu, HX; Zhang, LJ	1
Brandt, M; Burger, J; Challagundla, P; Faderl, S; Ferrajoli, A; Jorgensen, J; Kantarjian, H; Keating, M; Koller, C; Luthra, R; O'Brien, S; Pierce, S; Ravandi, F; Thomas, D; York, S	1
Achenbach, M; Bittenbring, JT	1
Setoodeh, R; Zhang, L	1
Ben-Yehuda, D; Ganzel, C; Gatt, ME; Goldschmidt, N; Maly, A	1
Bair, A; Gopaluni, S; Sanyal, S; Vajpayee, N	1
Naik, RR; Saven, A	1
Ergene, U; Işisağ, A; Ozbalcı, D	1
Alarcón-Urdaneta, C; Calderón-García, J; Gómez-Almaguer, D; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Tarín-Arzaga, LC	1
Annibali, O; Avvisati, G; Bianchi, A; Cerchiara, E; Cirillo, M; Gherardi, G; Girardi, K; Marchesi, F; Miglio, C; Onetti Muda, A; Paviglianiti, A; Tirindelli, M; Tomarchio, V	1
Daver, N; Haltom, R; Kantarjian, HM; Nazha, A; Ravandi, F	1
Al'-Radi, LS; Kravchenko, SK; Pivnik, AV; Zingerman, BV	1
Demeter, J; Nagy, Z; Sári, E	1
Bosch, F; Campo, E; Colomer, D; Giné, E; López-Guillermo, A; Montserrat, E; Rozman, M; Villamor, N	1
D'Silva, R; Papish, S; Tousi, B	1
Baudo, F; deCataldo, F	1
Betticher, D; Cerny, T; Fey, MF; Frickhofen, N; Ghielmini, M; Hess, U; Konwalinka, G; Piguet, D; Racine, C; Rufener, B; Schmitz, SF; Tichelli, A; Tobler, A; von Rohr, A; Wernli, M; Zulian, G	1
Bayle, J; Bernard, E; Cua, E; Dellamonica, P; Kaphan, R; Pulcini, C; Roth, S; Vandenbos, F	1
Del Vecchio, L; Ferrara, F; Morabito, P; Palmieri, S; Pocali, B; Pollio, F; Scalia, G	1
Glasmacher, A; Gorschlüter, M; Mey, U; Pralle, H; Schmidt-Wolf, I; Strehl, J; Ziske, C	1
Audeh, YM; Cherrington, A; Gruszecki, AC; Reddy, VV	1
Burian, C; Goodman, GR; Koziol, JA; Saven, A	1
Ogura, M	2
Bethel, K; Nieva, J; Saven, A	1
Catovsky, D; Matutes, E; Wotherspoon, A	1
Carson, DA; Leoni, LM	1
Beutler, E; Goodman, GR; Saven, A	1
Baker, PK; Cawley, JC; Harris, RJ; Kamiguti, AS; Slupsky, JR; Zuzel, M	1
Azagury, M; Duboucher, C; Flandrin, G; Martelli, JM; Morcelet, M	1
Huq, MH; Jamal, MF; Momen, A; Rahman, KM; Sarker, CB; Siddiqui, NI; Talukder, SI	1
Czerny, K; Kwietniewska, M; Sekita-Krzak, J; Stelmasiak, Z; Visconti, J	1
Cybulska, R; Czerny, K; Kwietniewska, M; Kwietniewski, P; Sekita-Krzak, J	2
Czerny, K; Kwietniewska, M	1
Bennett, M; Chubar, Y	1
Binda, BJ; Bow, EJ; Doucette, KE; Embil, JM; Galbraith, PA; Rendina, A	1
Pal, S; Said, J; Schiller, G	1
Golf, A; Haferlach, T; Hiddemann, W; Lenz, G; Rüdiger, T	1
Adigüzel, C; Argon, D; Bayik, M; Cetiner, M; Eksioglu-Demiralp, E; Ratip, S; Tecimer, T	1
Dedic, K; Zák, P	2
Alinari, L; Baccarani, M; Gabriele, A; Marchi, E; Musuraca, G; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL	1
Orlowski, RZ	1
Matsuda, K; Mitani, N; Miyazaki, M; Sakuragi, S; Shinohara, K; Taguchi, A	1
Araki, H; Kuribayashi, K; Kuroda, H; Matsunaga, T; Murase, K; Niitsu, Y; Terui, T	1
Bartl, R; Dietzfelbinger, H; Haferlach, T; Heinemann, V; Jehn, U	1
Barbashina, V; Bhargava, R; Filippa, DA; Teruya-Feldstein, J	1
Caracciolo, F; Cecconi, N; Cervetti, G; Galimberti, S; Petrini, M	1
Anavi, BL; Panchovska, MS; Solakov, PT; Spasov, EA; Tokmakova, KP	1
Gupta, M; Hassan, R; Kern, W; Ozer, H	1
Fietz, T; Knauf, W; Rieger, K; Schmittel, A; Thiel, E	1
Greyz, N; Saven, A	1
Andreazzoli, F; Caracciolo, F; Cecconi, N; Cervetti, G; Fazzi, R; Galimberti, S; Petrini, M	1
Imamura, T; Kashima, K; Kikuchi, H; Nasu, M; Ogata, M; Ohtsuka, E; Oka, F	1
Tallman, MS; Zakarija, A	1
Chadha, P; Evanchuk, DM; Hakimian, D; Kim, B; Mendiratta, P; Peterson, LC; Rademaker, AW; Tallman, MS	1
Adil, SN; Bilwani, F; Kakepoto, GN; Khurshid, M; Usman, M	1
Fenk, R; Gattermann, N; Germing, U; Haas, R; Kündgen, A; Strupp, C	1
Bila, J; Boskovic, D; Catovsky, D; Cemerikic, V; Elezovic, I; Gotic, M; Grujicic, D; Jocic, DJ; Magic, Z; Pavlovic, D; Stosic, T; Wotherspoon, A	1
Chou, T; Fujiyama, Y; Izumi, T; Katagiri, S; Kitani, T; Kitano, EK; Kitano, K; Machii, T; Nanba, K; Ohashi, Y; Ohe, Y; Shimazaki, C; Suzuki, M	1
Catovsky, D; Dearden, C; Del Giudice, I; Else, M; Matutes, E; Osuji, N; Ruchlemer, R; Swansbury, J; Woodman, A; Wotherspoon, A	1
Alobeid, B; Bhagat, G; Chu, KE; Tsao, L	1
Gratwohl, A; Rimner, T; Tichelli, A; Went, P	1
Ishigatsubo, Y; Kanamori, H; Sakai, R; Sakamoto, H; Yamazaki, E	1
Faderl, S; Ferrajoli, A; Freireich, EJ; Giles, FJ; Huang, X; Jones, D; Jorgensen, JL; Kantarjian, HM; Keating, MJ; Koller, CA; O'Brien, SM; Odinga, S; Ravandi, F; Thomas, DA; Verstovsek, S; Wierda, WG	1
Aschenafi, S; Baur, A; Delacretaz, F; Hsu-Schmitz, SF; Hurwitz, N; Kurrer, M; Mhawech-Fauceglia, P; Oberholzer, M; Von Rohr, A; Wagner, B	1
Dinçol, G; Kahraman, R	1
Azusawa, H; Katayama, I; Kokunai, A; Murata, S; Murota, H; Ohhata, C; Tadokoro, S	1
Belani, R; Saven, A	1
Cantello, R; Capello, D; Cerri, M; Conconi, A; Franceschetti, S; Gaidano, G; Lunghi, M; Rossi, D	1
Graber, P; Sendi, P; Wolf, A; Zimmerli, W	1
Gidron, A; Tallman, MS	1
Buckstein, R; Chesney, A; Imrie, K; Patel, H; Reis, M	1
Blonski, JZ; Calbecka, M; Ceglarek, B; Dmoszynska, A; Dwilewicz-Trojaczek, J; Dybowicz, J; Gawronski, K; Gora-Tybor, J; Hellmann, A; Jamroziak, K; Kasznicki, M; Kloczko, J; Konopka, L; Kostyra, A; Lewandowski, K; Molendowicz-Portala, L; Nowak, W; Robak, T; Seferynska, I; Skotnicki, AB; Sokolowski, J; Stella-Holowiecka, B; Sulek, K; Warzocha, K; Wiater, E; Wojtaszko, M; Zawilska, K; Zdunczyk, A; Zdziarska, B	1
Dincol, G; Diz-Kucukkaya, R; Inanc, M; Kamali, S; Kural, F	1
Josephine, FP; Nissapatorn, V	1
Catovsky, D; Dearden, C; Del Giudice, I; Else, M; Forconi, F; Lauria, F; Matutes, E; Osuji, N; Wotherspoon, A	1
Galimberti, S; Petrini, M; Riccioni, R	1
Becker, SE	1
Hirose, A; Ishiura, Y; Nakao, S; Okumura, H; Saito, K; Terasaki, Y; Yokawa, S	1
Amato, T; Forconi, F; Lauria, F; Raspadori, D; Sozzi, E; Toraldo, F	1
Chau, WK; Chen, CC; Chen, PM; Gau, JP; Ho, CH; Hsu, HC; Li, CY; You, JY; Yu, YB	1
Błasińska-Morawiec, M; Krykowski, E; Robak, T; Urbańska-Ryś, H	1
Hansz, J; Kaźmierczak, M; Komarnicki, M	1
Kraut, EH	1
Dyrda, S; Hakimian, D; Kiley, C; Nemcek, A; Peterson, L; Tallman, MS	1
Couban, S; Wilson, WE	1
Gollard, R; Lee, TC; Piro, LD; Saven, A	1
Flandrin, G; Troussard, X	1
Juliusson, G; Liliemark, J; Vitols, S	2
Heldal, D; Juliusson, G; Lenkei, R; Liliemark, J; Tjønnfjord, G	2
Bastion, Y; Bazin, M; Bryon, PA; Coiffier, B; Dumontet, C; Felman, P; Rieux, C	1
Bessa, O	1
Pawelski, S	1
Chrobák, L; Plísková, L; Podzimek, K; Voglová, J; Zak, P	1
Hiddemann, W; Pott-Hoeck, C	1
Bendandi, M; Ricci, P; Tura, S; Zinzani, PL	1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A	1
Hakimian, D; Kiley, C; Peterson, L; Tallman, MS	1
Anderson, WF; Elias, AL; Pankey, LR; Reeves, JE; Robbins, BA	1
Albertioni, F; Evensen, SA; Hedenus, M; Heldal, D; Hippe, E; Juliusson, G; Malm, C; Stolt, CM; Tjønnfjord, G; Wallman, K	1
Chan, DW; Chan, TK; Chiu, E; Kwong, YL; Liang, R	1
Arnér, ES; Brosjö, O; Eriksson, S; Gunvén, P; Juliusson, G; Liliemark, J; Spasokoukotskaja, T	1
Estey, EH; Keating, MJ; Kurzrock, R; Seymour, JF	1
Barak, V; Cass, Y; Dann, EJ; Gillis, S; Polliack, A; Rachmilewitz, EA; Ruchlemer, R	1
Ellison, DJ; Piro, LD; Saven, A	1
Carbone, A; di Celle, PF; Foà, R; Lauria, F; Raspadori, D; Reato, G; Rondelli, D	1
Benfenati, D; Benni, M; Lauria, F; Pileri, S; Poggi, S; Raspadori, D; Rondelli, D; Sabattini, E; Tura, S; Ventura, MA	1
Catovsky, D; Matutes, E; Mercieca, J; Moskovic, E; Puga, M; Salim, S	1
Benfenati, D; Benni, M; Falini, B; Merla, E; Pileri, S; Poggi, S; Raspadori, D; Rondelli, D; Sabattini, E; Ventura, MA	1
Arena, FP	1
Anand, A	1
Benfenati, D; Lauria, F; Raspadori, D; Rondelli, D; Tura, S	1
Piro, L; Saven, A	1
Hakimian, D; Hogan, DK; Nemcek, AA; Rademaker, AW; Rose, E; Tallman, MS	1
Benfenati, D; Lauria, F; Raspadori, D; Rondelli, D; Tura, S; Zinzani, PL	1
Piro, LD; Saven, A	4
Piro, LD	1
Estey, EH; Freireich, EJ; Kurzrock, R; Seymour, JF	1
Alothman, A; Sparling, TG	1
Florena, AM; Franco, V; Musso, M; Quintini, G	1
Juliusson, G; Lenkei, R; Liliemark, J	1
Evensen, SA; Heldal, D; Juliusson, G; Tjønnfjord, GE	1
Hippe, E; Juliusson, G; Nielsen, OJ; Priø, TK	1
Bosly, A; Delannoy, A; Doyen, C; Driesschaert, P; Ferrant, A; Filleul, B; Glorieux, P; Mineur, P; Van Daele, S; Zenebergh, A	1
Golomb, HM; Platanias, LC	1
Drake, D; Fitzgerald-Bocarsly, P; Hoffman, M; Janson, D; Rai, KR; Sawitsky, A; Shah, K; Shodell, M; Siegal, FP	1
Ben-Bassat, I; Raanani, P; Shpilberg, O	1
Arnér, E; Brosjö, O; Eriksson, S; Gunvén, P; Julusson, G; Karlsson, A; Liliemark, J; Spasokoukotskaja, T; Wang, L	1
Carbone, A; Di Celle, PF; Foa, R; Lauria, F; Reato, G	1
Fedak, MN	1
Arnér, ES; Eriksson, S; Juliusson, G; Liliemark, J; Spasokoukotskaja, T	1
Ellison, DJ; Leopard, JD; Piro, LD; Robbins, BA; Saven, A; Sharpe, RW; Spinosa, JC	1
Carrera, CJ; Carson, DA; Kawasaki, H; Kipps, TJ; Piro, LD; Saven, A	1
Ozes, ON; Reiter, Z; Taylor, MW; Tomson, S	1
Kaźmierczak, M; Komarnicki, M	1
Hogan, DK; Nelson, MC	1
Djaldetti, M; Eting, E; Mittelman, M; Robinson, A; Savir, H; Zeidman, A	1
De Stefano, V; Etuk, B; Leone, G; Martucci, R; Peschle, C; Rumi, C; Rutella, S; Sica, S; Testa, U	1
Hakimian, D; Peterson, L; Tallman, MS; Wheaton, S	1
Krygier-Stojałowska, A; Urasiński, I; Zdziarska, B	1
Catovsky, D; Coles, H; Emmett, E; Matutes, E; Mercieca, J	1
Bosly, A; Delannoy, A; Ferrant, A; Filleul, B; Martiat, P; Michaux, JL; Mineur, P; Montfort, L; Straetmans, N; Van Den Neste, E; Vandercam, B	1
Błasińska-Morawiec, M; Dwilewicz-Trojaczek, J; Grieb, P; Hansz, J; Hellmann, A; Hołowiecki, J; Kazimierczak, M; Komarnicki, M; Konopka, L; Kotlarek-Haus, S; Krawczyk-Kulis, M; Krykowski, E; Kuratowska, Z; Maj, S; Robak, T; Urasiński, L; Usnarska-Zubkiewicz, L; Zaucha, JM; Zdziarska, B	1
Guerci, A; Lederlin, P; Paitel, JF	1
Bogman, MJ; Raemaekers, JM; van 't Veer, MB	1
Juliusson, G	1
Hakimian, D; Peterson, LC; Rademaker, AW; Rose, E; Tallman, MS; Wollins, E; Zanzig, C	1
Djaldeti, M; Floru, S; Mittelman, M; Polliack, A; Robinson, A; Savir, H; Zeidman, A	1
Fend, F; Geisen, F; Hilbe, W; Knoblechner, A; Konwalinka, G; Petzer, A; Schirmer, M; Thaler, J	1
Beham-Schmid, C; Höfler, G; Linkesch, W; Schmidt, HH; Sill, H	1
Aractingi, S; Bastie, JN; Castaigne, S; Chosidow, O; Meunier, P	1
Hershko, C; Rosenmann, E; Zevin, S	1
Chrobák, L; Kerekes, Z; Palicka, V; Plísková, L; Podzimek, K; Spacek, J; Voglová, J; Zák, P	1
Góra-Tybor, J; Robak, T	1
Bocchia, M; Lauria, F; Marotta, G; Raspadori, D; Rondelli, D; Zinzani, PL	2
Hoffman, MA; Janson, D; Rai, KR; Rose, E	1
Geisen, F; Hilbe, W; Konwalinka, G; Schirmer, M; Thaler, J	1
Albitar, M; Bueso-Ramos, C; Copeland, AR; Huh, YO; Kornblau, SM; Liu, FJ	1
Adams, T; Estey, E; Jiang, H; Keating, MJ; Kurzrock, R; O'Brien, S; Strom, SS; Talpaz, M	1
Blasińska-Morawiec, M; Hellmann, A; Krykowski, E; Robak, T; Urbańska-Ryś, H	1
Arrossagaray, G; Bengió, R; Pérez, M; Raña, P; Sánchez Lucero, A; Sarmiento, M; Sarto, A	1
Hotta, T; Kinoshita, T; Kobayashi, Y; Kozuru, M; Narabayashi, M; Ogura, M; Ohashi, Y; Suzuki, R; Tobinai, K; Uike, N	1
Hakimian, D; Pandolfino, J; Rademaker, AW; Tallman, MS	1
Cohen, PR; Kurzrock, R	2
Bernstein, SH; Koczwara, B; Spangenthal, E	1
Delmer, A; Legrand, O; Marie, JP; Vekhoff, A; Zittoun, R	1
Chrobák, L; Dĕdic, K; Dulícek, P; Foglová, J; Maisnar, V; Plísková, L; Podzimek, K; Zák, P	1
Haanen, C; Idink-Mecking, CA; Reutelingsperger, C; Richel, DJ; Schaafsma, MR; Vermes, I	1
al-Katib, AM; Almatchy, VP; Katato, K; Liu, KZ; Mantsch, HH; Mohammad, RM; Schultz, CP; Varterasian, M; Wall, N	1
Bruni, R; Cerri, R; Clavio, M; Damasio, EE; Isaza, A; Masoudi, B; Resegotti, L; Risso, M; Rossi, E; Spriano, M; Truini, M	1
Polliack, A	1
Rai, KR	1
Au, WY; Connors, JM; Gallagher, R; Gascoyne, RD; Klasa, RJ; Le, N	1
Burian, C; Koziol, JA; Piro, LD; Saven, A	1
Annino, L; Barrett, JA; Cheson, BD; Coiffier, B; Connors, J; Damasio, E; Lauria, F; Montello, MJ; Sorensen, JM; Tallman, M; Vena, DA	1
Ikpeazu, EV; Kaplon, MK	1
Chrobák, L; Dedic, K; Plísková, L; Podzimek, K; Zák, P	1
Błasińska-Morawiec, M; Błoński, J; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Hansz, J; Hałaburda, K; Hellmann, A; Hołowiecki, J; Konopka, L; Kotlarek-Haus, S; Potoczek, S; Robak, T; Skotnicki, AB; Urasiński, I; Zdziarska, B	1
Arat, M; Beksaç, M; Idilman, R	1
Machaczka, M; Rucińska, M; Skotnicki, AB; Załuska, A	1
Adusumalli, J; Burian, C; Koziol, JA; Saven, A	1
Bartl, R; Dietzfelbinger, H; Heinemann, V; Hill, W; Jehn, U; Vehling-Kaiser, U; Wolf-Hornung, B	1
Dujardin, P; Guzman-Granier, E; Jullien, V; Michiels, JF; Perrin, C; Peyrade, F; Sanderson, F; Taillan, B	1
Gillis, S; Hakimian, D; Peterson, LC; Polliack, A; Tallman, MS	1
Dunphy, CH; Oza, YV; Skelly, ME	1
Berger, R; Gruber, G; Hilgarth, M; Schwarzmeier, JD; Shehata, M	1
Ilyas, W; Mann, R; Myers, D; Seraly, MP	1
Cassileth, PA; Foucar, K; Grever, M; Habermann, T; Hakimian, D; Kopecky, KJ; Peterson, LC; Rowe, JM; Tallman, MS; Wheaton, S; Wollins, E	1
Birtolo, S; Lauria, F; Lenoci, M; Marotta, G; Nardi, G; Raspadori, D; Rondelli, D; Scalia, G; Sestigiani, C; Tozzi, M	1
Al-Fiar, F; Curtis, J; Lipton, JH; Meharchand, J	1
Catovsky, D; Dearden, CE; Hilditch, BL; Matutes, E; Swansbury, GJ	1
Hakimian, D; Meyer, J; Peterson, LC; Siegel, RS; Spies, W; Tallman, MS; Wollins, ER	1
Berger, T; Hilbe, W; Konwalinka, G; Thaler, J	1
Browne, PV; Chacko, J; Duggan, C; McCann, SR; Murphy, C; O'Briain, DS	1
Bastie, JN; Castaigne, S; Cazals-Hatem, D; D'Agay, MF; Dabout, D; Daniel, MT; Degos, L; Dombret, H; Flandrin, G; Glaisner, S; Noel-Walter, MP; Poisson, D; Rabian, C	1
Chott, A; Füreder, W; Geissler, K; Gisslinger, H; Jäger, U; Lechner, K; Valent, P; Weltermann, A	1
Robbins, BA; Saven, A; Tetreault, SA	1
Broady, R; Hawkins, T; Roberts, S	1
Flanagan, NG; Grey, MR; Kelsey, PR	1
Geisen, F; Grünewald, K; Haun, M; Hilbe, W; Konwalinka, G; Schirmer, M; Thaler, J	1
Juneja, SK; Westerman, DA	1
Corbett, WE; Daeninck, PJ; Eisenhauer, E; Johnston, JB; Wainman, N; Zaentz, SD	1
Seshadri, P	1
Bendandi, M; Cellini, C; Magagnoli, M; Piccioli, M; Pileri, S; Poggi, S; Stefoni, V; Tani, M; Tura, S; Zinzani, PL	1
Bradlow, B; Platanias, LC; Stock, W; Usha, L	1
Amir, G; Bennett, M; Gillis, S; Polliack, A	1
Bengio, R; Narbaitz, M; Palacios, F; Sarmiento, M; Scolnik, M	1
Andrey, J; Saven, A	1
Ho, CH; Yang, MH	1
Bengió, RM; Fornari, MC; Neme, D; Sarmiento, MA	1
Chrobák, L; Dĕdic, K; Podzimek, K; Zák, P	1
Hendrick, A	1
Braylan, RC; Cornfield, DB; Mitchell Nelson, DM; Moller-Patti, D; Rimsza, LM	1
Bergeron, K; FitzGerald, DJ; Kreitman, RJ; Pastan, I; Raggio, M; Stetler-Stevenson, M; Wilson, WH	1
Becker, C	1
Abhyankar, D; Advani, S; Saikia, T	1
Saven, A	1
Azaceta, G; Calvo, MT; Domingo, JM; Gutierrez, M; Palomera, L; Sola, C	1
Babuŝíková, O; Gyárfás, J; Kusenda, J; Tomová, A	1
Bellanger, C; Bourguin-Plonquet, A; Delfau-Larue, MH; Diviné, M; Farcet, JP; Marquet, J; Rouard, H; Roudot-Thoraval, F	1
Caggiano, J; Golde, DW; Heaney, ML; Jakubowiak, A	1
Ghanima, W; Heldal, D; Tjønnfjord, GE	1
Johnston, JB; Savoie, L	1
Indrák, K; Papajík, T; Pikalová, Z; Raida, L; Zapletalová, J	1
Golomb, HM; Spielberger, RT	1
Juliusson, G; Liliemark, J	2
Beran, M; Estey, EH; Hirsch-Ginsberg, C; Huh, YO; Kantarjian, HM; Keating, MJ; Koller, C; Kurzrock, R; McCredie, KB; O'Brien, SM	1
Hagberg, H	1
Carrera, CJ; Carson, DA; Cottam, HB; Esparza, LM; Kipps, TJ; Wasson, DB	1
Nightingale, SL	1
Daly, K; Golomb, HM; Mick, R; Ratain, MJ	1
Cheson, BD	1
Beutler, E	1
Hakimian, D; Kaul, K; Koslow, D; Rademaker, AW; Rose, E; Sisney, GA; Tallman, MS; Variakojis, D	1
Benfenati, D; Lauria, F; Pallotti, A; Raspadori, D; Rondelli, D; Tura, S	1
Błasińska-Morawiec, M; Krykowski, E; Robak, T	1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A; Terai, C	1
Blatt, LM; Ozes, ON; Reiter, Z; Taylor, MW; Tomson, S	1
Golde, DW; Lill, MC	1
Gutterman, JU; Kurzrock, R; Talpaz, M	1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD	1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Wasson, DB	1

Reviews

83 review(s) available for cladribine and Hairy Cell Leukemia

Article	Year
CD103-CD23+ classical hair cell leukemia: A case report and review of the literature. Medicine, 2021, Dec-23, Volume: 100, Issue:51 Topics: Antigens, CD; Antineoplastic Agents; Cladribine; Female; Humans; Immunophenotyping; Integrin alpha Chains; Leukemia, Hairy Cell; Middle Aged; Neoplasm, Residual; Receptors, IgE; Rituximab; Treatment Outcome	2021
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Current oncology reports, 2022, Volume: 24, Issue:9 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Proto-Oncogene Proteins B-raf; Rituximab; Tumor Microenvironment	2022
Increased risk of severe cutaneous adverse reactions when cladribine is used together with other medications with a propensity for skin reactions. Leukemia & lymphoma, 2022, Volume: 63, Issue:12 Topics: Allopurinol; Cladribine; Humans; Leukemia, Hairy Cell; Skin; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. American journal of hematology, 2019, Volume: 94, Issue:12 Topics: Algorithms; Antimetabolites, Antineoplastic; B-Lymphocytes; Biopsy; Bone Marrow Examination; Cladribine; Humans; Immunophenotyping; Immunotoxins; Leukemia, Hairy Cell; Middle Aged; Mutation, Missense; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Risk Assessment; Rituximab; Salvage Therapy	2019
The pharmacological management of hairy cell leukemia. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Toxins; Cladribine; Clinical Trials, Phase II as Topic; Exotoxins; Humans; Interferon-alpha; Leukemia, Hairy Cell; Remission Induction; Rituximab; Splenectomy	2020
Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis. Clinical lymphoma, myeloma & leukemia, 2018, Volume: 18, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Leukemia, Hairy Cell; Neoplasm Recurrence, Local; Remission Induction; Rituximab; Treatment Outcome; Vemurafenib	2018
CD56-Positive Acute Myeloid Leukemia Following Treatment of Hairy Cell Leukemia with Cladribine - Report of 2 Cases and Review of the Literature. Archives of Iranian medicine, 2019, 05-01, Volume: 22, Issue:5 Topics: Antineoplastic Agents; CD56 Antigen; Cladribine; Fatal Outcome; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Remission Induction	2019
Update on the biology and treatment options for hairy cell leukemia. Current treatment options in oncology, 2014, Volume: 15, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; B-Lymphocytes; Cladribine; Disease-Free Survival; Humans; Immunophenotyping; Immunotoxins; Indoles; Leukemia, Hairy Cell; Mutation; Pentostatin; Proto-Oncogene Proteins B-raf; Recombinant Proteins; Recurrence; Rituximab; Sulfonamides; Vemurafenib	2014
Hairy cell leukemia: update and current therapeutic approach. Current opinion in hematology, 2015, Volume: 22, Issue:4 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Clinical Trials as Topic; Gene Expression; Humans; Imidazoles; Indoles; Leukemia, Hairy Cell; Mutation; Oximes; Pentostatin; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Recurrence; Remission Induction; Sulfonamides; Vemurafenib	2015
Historical overview of hairy cell leukemia. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Disease Management; History, 20th Century; History, 21st Century; Humans; Immunotoxins; Indoles; Leukemia, Hairy Cell; Mutation; Pentostatin; Proto-Oncogene Proteins B-raf; Remission Induction; Rituximab; Splenectomy; Sulfonamides; Survival Analysis; Vemurafenib	2015
Long-term follow-up after purine analogue therapy in hairy cell leukaemia. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Follow-Up Studies; Humans; Indoles; Leukemia, Hairy Cell; Mutation; Pentostatin; Prognosis; Proto-Oncogene Proteins B-raf; Recurrence; Remission Induction; Rituximab; Sulfonamides; Survival Analysis; Vemurafenib	2015
Chemoimmunotherapy for hairy cell leukemia. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cladribine; Humans; Immunotherapy; Leukemia, Hairy Cell; Mutation; Pentostatin; Prognosis; Proto-Oncogene Proteins B-raf; Recurrence; Remission Induction; Rituximab; Survival Analysis	2015
Immunoconjugates in the management of hairy cell leukemia. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Toxins; Cladribine; Clinical Trials as Topic; Exotoxins; Humans; Immunoconjugates; Leukemia, Hairy Cell; Mutation; Neoplasm, Residual; Pentostatin; Peptide Elongation Factor 2; Proto-Oncogene Proteins B-raf; Remission Induction; Survival Analysis	2015
Hairy cell leukaemia-variant: Disease features and treatment. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Aged; Antigens, CD; Antineoplastic Agents; B-Lymphocytes; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 17; Cladribine; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphocytosis; Male; MAP Kinase Kinase 1; Mutation; Rituximab; Spleen; Splenomegaly; Survival Analysis; Tumor Suppressor Protein p53	2015
Hairy cell leukemia: Past, present and future. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Disease Management; History, 20th Century; History, 21st Century; Humans; Immunotoxins; Indoles; Leukemia, Hairy Cell; Mutation; Pentostatin; Proto-Oncogene Proteins B-raf; Remission Induction; Rituximab; Splenectomy; Sulfonamides; Survival Analysis; Vemurafenib	2015
Letting post-marketing bridge the evidence gap: the case of orphan drugs. BMJ (Clinical research ed.), 2016, Jun-22, Volume: 353 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate	2016
How I manage patients with hairy cell leukaemia. British journal of haematology, 2017, Volume: 177, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cladribine; Diagnosis, Differential; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Mutation; Opportunistic Infections; Pentostatin; Proto-Oncogene Proteins B-raf; Purine Nucleosides; Rituximab; Social Support; Splenectomy; Treatment Outcome	2017
Hairy cell leukemia: current concepts. Cancer investigation, 2008, Volume: 26, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow Examination; Cladribine; Combined Modality Therapy; Diagnosis, Differential; Female; Forecasting; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Rituximab; Salvage Therapy; Splenomegaly; Treatment Outcome	2008
[Hairy cell leukemia: Part II: therapy with cladribine]. Medizinische Monatsschrift fur Pharmazeuten, 2009, Volume: 32, Issue:7 Topics: Animals; Antineoplastic Agents; Cladribine; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Prognosis	2009
Cladribine in the treatment of hairy cell leukemia: initial and subsequent results. Leukemia & lymphoma, 2009, Volume: 50 Suppl 1 Topics: Algorithms; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia, Hairy Cell; Models, Biological; Neoplasm, Residual; Purines	2009
Approach to the patient after relapse of hairy cell leukemia. Leukemia & lymphoma, 2009, Volume: 50 Suppl 1 Topics: Algorithms; Antibodies, Monoclonal; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Humans; Immunotoxins; Interleukin-2 Receptor alpha Subunit; Leukemia, Hairy Cell; Recombinant Proteins; Recurrence; Sialic Acid Binding Ig-like Lectin 2	2009
Risk of additional cancers in untreated and treated hairy cell leukemia patients. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Incidence; Leukemia, Hairy Cell; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pentostatin	2010
Which role for rituximab in hairy cell leukemia? Reflections on six cases. Acta haematologica, 2010, Volume: 123, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Rituximab; Treatment Outcome	2010
Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood, 2010, Oct-21, Volume: 116, Issue:16 Topics: Antineoplastic Agents; Cladribine; Hematologic Neoplasms; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia	2010
Chemo-immunotherapy for hairy cell leukemia. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Leukemia, Hairy Cell; Neoplasm, Residual; Pentostatin; Rituximab	2011
Mechanism of action of pentostatin and cladribine in hairy cell leukemia. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Apoptosis; Cladribine; DNA Breaks; Humans; Leukemia, Hairy Cell; Pentostatin	2011
Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Cladribine; Humans; Immunohistochemistry; Immunophenotyping; Leukemia, Hairy Cell; Neoplasm, Residual	2011
Purine analog toxicity in patients with hairy cell leukemia. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Purines; Vidarabine	2011
Alternative methods of cladribine administration. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Cladribine; Drug Administration Routes; Drug Administration Schedule; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Treatment Outcome	2011
Insight into the behavior of hairy cell leukemia by immunogenetic analysis. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Cladribine; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Prognosis; Receptors, Antigen, B-Cell	2011
Development of cladribine at Scripps for hairy cell leukemia and current results. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Cladribine; Humans; Leukemia, Hairy Cell; Neoplasm, Residual; Salvage Therapy; Treatment Outcome	2011
Fifty years of hairy cell leukemia treatments. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Antibodies, Monoclonal, Murine-Derived; Cladribine; Humans; Leukemia, Hairy Cell; Pentostatin; Rituximab; Treatment Outcome	2011
Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Adenosine Deaminase Inhibitors; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Pentostatin; Treatment Outcome	2011
Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Registries; Survival Analysis; Sweden	2011
Hairy cell leukaemia: biological and clinical overview from immunogenetic insights. Hematological oncology, 2011, Volume: 29, Issue:2 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cladribine; Humans; Immunogenetic Phenomena; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Mutation; Receptors, Antigen, B-Cell; Rituximab	2011
Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature. Leukemia & lymphoma, 2012, Volume: 53, Issue:4 Topics: Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 9; Cladribine; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic	2012
[Recurrent somatic mutation in hairy cell leukemia]. Orvosi hetilap, 2013, Jan-27, Volume: 154, Issue:4 Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Cladribine; Diagnosis, Differential; Disease-Free Survival; Humans; Hungary; Interferons; Leukemia, Hairy Cell; Mutation; Neoplasm Staging; Pancytopenia; Pentostatin; Purine Nucleosides; Remission Induction; Splenectomy; Splenomegaly; Watchful Waiting	2013
Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association? Leukemia, 2002, Volume: 16, Issue:8 Topics: Antimetabolites, Antineoplastic; B-Lymphocytes; Cell Lineage; Cladribine; Combined Modality Therapy; Comorbidity; Gene Rearrangement, B-Lymphocyte; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mass Screening; Middle Aged; Neoplasms, Multiple Primary; Neoplastic Stem Cells; Pentostatin; Prospective Studies; Remission Induction; Salvage Therapy; Transplantation, Autologous	2002
Advances in the treatment of hairy-cell leukaemia. The Lancet. Oncology, 2003, Volume: 4, Issue:2 Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Cell Adhesion Molecules; Cladribine; Humans; Interferon-alpha; Lectins; Leukemia, Hairy Cell; Neoplasm, Residual; Neoplasms, Second Primary; Pancytopenia; Pentostatin; Receptors, Interleukin-2; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Spleen; Splenectomy; Splenomegaly; Treatment Outcome; Vidarabine	2003
[Cladribine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:2 Topics: Aged; Antineoplastic Agents; Cladribine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Female; Humans; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged	2003
The variant form of hairy-cell leukaemia. Best practice & research. Clinical haematology, 2003, Volume: 16, Issue:1 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Diagnosis, Differential; Humans; Immunophenotyping; Interferon-alpha; Leukemia, Hairy Cell; Male; Survival Analysis	2003
Hairy-cell leukaemia as a model for drug development. Best practice & research. Clinical haematology, 2003, Volume: 16, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase 9; Caspases; Cladribine; Drug Evaluation; Humans; Leukemia, Hairy Cell; Poly(ADP-ribose) Polymerases; Proteins	2003
Cladribine in the treatment of hairy-cell leukaemia. Best practice & research. Clinical haematology, 2003, Volume: 16, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dose-Response Relationship, Drug; Follow-Up Studies; Growth Substances; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Salvage Therapy	2003
Immunobiological treatments of hairy-cell leukaemia. Best practice & research. Clinical haematology, 2003, Volume: 16, Issue:1 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Exotoxins; Humans; Immunotoxins; Leukemia, Hairy Cell; Models, Biological; Remission Induction; Time Factors	2003
Hairy cell leukemia in father and son. Medical oncology (Northwood, London, England), 2003, Volume: 20, Issue:4 Topics: Aged; Antineoplastic Agents; Cladribine; Haplotypes; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged	2003
[Hairy cell leukemia therapy by cladribine]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:7 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell	2004
Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature. Leukemia & lymphoma, 2004, Volume: 45, Issue:10 Topics: Acute Disease; Aged; Cladribine; Fatal Outcome; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Pancytopenia	2004
Cladribine: from the bench to the bedside--focus on hairy cell leukemia. Expert review of anticancer therapy, 2004, Volume: 4, Issue:5 Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Hairy Cell; Lymphocytes; Monocytes; Survival Analysis	2004
Hairy cell leukemia: survival and relapse. Long-term follow-up of purine analog-based therapy and approach for relapsed disease. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2005, Volume: 32, Issue:1 Topics: ADP Ribose Transferases; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Bacterial Toxins; Cell Adhesion Molecules; Cladribine; Clinical Trials as Topic; Exotoxins; Follow-Up Studies; Humans; Immunosuppressive Agents; Lectins; Leukemia, Hairy Cell; Pentostatin; Pseudomonas aeruginosa Exotoxin A; Recurrence; Remission Induction; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Time Factors; Treatment Outcome; Virulence Factors	2005
Cladribine in hairy cell leukemia. Hematology/oncology clinics of North America, 2006, Volume: 20, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Disease-Free Survival; Genes, Immunoglobulin Heavy Chain; Humans; Italy; Leukemia, Hairy Cell; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Rituximab; Treatment Outcome	2006
Pentostatin: impact on outcome in hairy cell leukemia. Hematology/oncology clinics of North America, 2006, Volume: 20, Issue:5 Topics: Ambulatory Care; Antibiotics, Antineoplastic; Cladribine; Clinical Trials as Topic; Disease-Free Survival; Humans; Leukemia, Hairy Cell; Monitoring, Physiologic; Neoplasm, Residual; Pentostatin; Recurrence	2006
2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up. Leukemia & lymphoma, 2006, Volume: 47, Issue:11 Topics: Cladribine; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Recurrence; Time Factors; Treatment Outcome	2006
Development of hairy cell leukemia in a patient with antiphospholipid syndrome. Lupus, 2007, Volume: 16, Issue:4 Topics: Adult; Antibodies, Antiphospholipid; Antineoplastic Agents; Antiphospholipid Syndrome; Cladribine; Female; Humans; Leukemia, Hairy Cell; Remission Induction	2007
Hairy Cell Leukemia. Current treatment options in oncology, 2007, Volume: 8, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Humans; Interferons; Leukemia, Hairy Cell; Rituximab; Splenectomy	2007
The disease with hope: hairy cell leukemia. Clinical journal of oncology nursing, 2007, Volume: 11, Issue:5 Topics: Antibodies; Antineoplastic Agents; Cladribine; Enterotoxins; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Prognosis; Remission Induction; Splenectomy; Treatment Outcome	2007
The optimal management of hairy cell leukaemia. Drugs, 1995, Volume: 49, Issue:6 Topics: Antineoplastic Agents; Cladribine; Combined Modality Therapy; Granulocyte Colony-Stimulating Factor; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin; Splenectomy; Vidarabine	1995
[Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)]. Acta haematologica Polonica, 1995, Volume: 26, Issue:2 Topics: Apoptosis; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Remission Induction	1995
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Purines; Vidarabine	1995
Hairy cell leukemia: new understanding of biology and treatment. Cancer treatment and research, 1993, Volume: 64 Topics: Cladribine; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin	1993
Newer purine analogues for the treatment of hairy-cell leukemia. The New England journal of medicine, 1994, Mar-10, Volume: 330, Issue:10 Topics: Cladribine; Clinical Trials as Topic; Humans; Leukemia, Hairy Cell; Lymphocytes; Pentostatin; Remission Induction	1994
2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Leukemia & lymphoma, 1993, Volume: 11 Suppl 2 Topics: Cladribine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell	1993
2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma. Seminars in hematology, 1993, Volume: 30, Issue:4 Suppl 6 Topics: Cladribine; Clinical Trials as Topic; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell	1993
Hairy cell leukaemia. Bailliere's clinical haematology, 1993, Volume: 6, Issue:4 Topics: Adult; Cladribine; Clinical Trials as Topic; Female; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pancytopenia; Pentostatin; Prognosis; Remission Induction; Splenectomy; Splenomegaly; Treatment Outcome	1993
[2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia]. Harefuah, 1994, Jun-01, Volume: 126, Issue:11 Topics: Cladribine; Humans; Leukemia, Hairy Cell	1994
Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy. Advances in enzyme regulation, 1994, Volume: 34 Topics: Adenocarcinoma; Burkitt Lymphoma; Cells, Cultured; Cladribine; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukocytes, Mononuclear; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Sarcoma	1994
2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies. Leukemia & lymphoma, 1993, Volume: 10 Suppl Topics: Cladribine; Humans; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous	1993
2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia. Cancer investigation, 1993, Volume: 11, Issue:5 Topics: Cladribine; Humans; Leukemia, Hairy Cell; Splenectomy	1993
The role of cladribine in the treatment of lymphoid malignancies. Oncology nursing forum, 1995, Volume: 22, Issue:9 Topics: Antineoplastic Agents; Cladribine; Drug Monitoring; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Oncology Nursing; Patient Care Planning	1995
[Hairy cell leukemia: therapeutic approaches]. La Revue de medecine interne, 1996, Volume: 17, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin	1996
[Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)]. Przeglad lekarski, 1996, Volume: 53, Issue:8 Topics: Animals; Antineoplastic Agents; Cladribine; Humans; Leukemia L1210; Leukemia, Hairy Cell; Lymphoproliferative Disorders	1996
Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options. Leukemia & lymphoma, 1997, Volume: 26 Suppl 1 Topics: Antineoplastic Agents; Biomarkers, Tumor; Cladribine; Diagnosis, Differential; Humans; Interferon-alpha; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Lymphoma, Non-Hodgkin; Pentostatin; Prognosis	1997
Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Seminars in oncology, 1998, Volume: 25, Issue:3 Suppl 7 Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Remission Induction; Treatment Outcome	1998
[Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy]. Przeglad lekarski, 1998, Volume: 55, Issue:7-8 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Neoplasm, Residual; Pentostatin; Remission Induction; Splenectomy; Vidarabine	1998
Treatment of hairy-cell leukemia: current views. Seminars in hematology, 1999, Volume: 36, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy	1999
Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature. Leukemia research, 1999, Volume: 23, Issue:8 Topics: Acute Disease; Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary	1999
Therapeutic advances in the treatment of hairy cell leukemia. Leukemia research, 2001, Volume: 25, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Immunotoxins; Interferon alpha-2; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Recombinant Proteins; Splenectomy	2001
Hairy cell leukemia. Current treatment options in oncology, 2001, Volume: 2, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin; Splenectomy	2001
Hairy cell leukemia 1992. Leukemia, 1992, Volume: 6 Suppl 4 Topics: Cladribine; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin; Splenectomy	1992
The treatment of hairy cell leukemia: an update. Leukemia, 1992, Volume: 6 Suppl 2 Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy	1992
Cladribine (2-chlorodeoxyadenosine) Lancet (London, England), 1992, Oct-17, Volume: 340, Issue:8825 Topics: Cladribine; Humans; Leukemia; Leukemia, Hairy Cell; Lymphoma	1992
Treatment of hairy-cell leukemia. Blood reviews, 1990, Volume: 4, Issue:4 Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy	1990
Hairy cell leukaemia: review of treatment. British journal of haematology, 1991, Volume: 79 Suppl 1 Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Granulocyte Colony-Stimulating Factor; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy	1991
Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia. Advances in experimental medicine and biology, 1989, Volume: 253A Topics: 2-Chloroadenosine; Adenosine Deaminase; Anemia, Hemolytic, Autoimmune; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell	1989

Trials

42 trial(s) available for cladribine and Hairy Cell Leukemia

Article	Year
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant. Blood advances, 2021, 12-14, Volume: 5, Issue:23 Topics: Cladribine; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Remission Induction; Rituximab	2021
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood advances, 2020, 08-11, Volume: 4, Issue:15 Topics: Antineoplastic Agents; Child, Preschool; Cladribine; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Prospective Studies	2020
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial. British journal of haematology, 2016, Volume: 174, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Recurrence; Remission Induction; Rituximab	2016
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95. Leukemia & lymphoma, 2009, Volume: 50, Issue:1 Topics: Cladribine; Female; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Neoplasm Staging; Survival Rate	2009
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jun-20, Volume: 27, Issue:18 Topics: Adult; Aged; Antibodies; Antineoplastic Agents; Cladribine; Drug Resistance; Enterotoxins; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Prospective Studies; Spleen; Treatment Outcome	2009
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. Blood, 2009, Nov-19, Volume: 114, Issue:21 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; DNA Mutational Analysis; Drug Resistance, Neoplasm; Female; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Leukemia, Hairy Cell; Male; Middle Aged; Mutation; Prognosis; Treatment Outcome; Tumor Suppressor Protein p53	2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leukemia & lymphoma, 2009, Volume: 50, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Remission Induction; Treatment Outcome; Young Adult	2009
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia. Blood, 2011, Oct-06, Volume: 118, Issue:14 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Rituximab; Treatment Outcome	2011
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Disease Progression; Female; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Leukopenia; Male; Middle Aged; Recurrence; Survival	2002
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood, 2003, Aug-01, Volume: 102, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Blood Cell Count; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutrophils; Remission Induction; Rituximab; Salvage Therapy; Treatment Failure; Treatment Outcome	2003
Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:4 Topics: Aged; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome; Waldenstrom Macroglobulinemia	2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemia. European journal of haematology, 2004, Volume: 73, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Cladribine; Combined Modality Therapy; Female; Humans; Hypotension; Immunization, Passive; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Remission Induction; Rituximab; Treatment Outcome	2004
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood, 2005, Jul-01, Volume: 106, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Survival Analysis; Time Factors	2005
Phase II clinical study of cladribine in the treatment of hairy cell leukemia. International journal of hematology, 2005, Volume: 82, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Treatment Outcome	2005
Eradication of minimal residual disease in hairy cell leukemia. Blood, 2006, Jun-15, Volume: 107, Issue:12 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cladribine; Female; Flow Cytometry; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Rituximab	2006
Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia. Archives of pathology & laboratory medicine, 2006, Volume: 130, Issue:3 Topics: Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Bone Marrow Cells; Cladribine; Follow-Up Studies; Humans; Immunohistochemistry; Injections, Subcutaneous; Leukemia, Hairy Cell; Neoplasm, Residual; Predictive Value of Tests; Remission Induction; Retrospective Studies	2006
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial. Blood, 2007, May-01, Volume: 109, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Middle Aged; Poland; Prospective Studies; Remission Induction; Sepsis; Survival Rate	2007
Treatment of patients with hairy cell leukemia with 2-chloro-2'-deoxyadenosine (2-CdA). Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Cladribine; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Middle Aged; Splenectomy	1994
Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA). Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:1 Topics: Adult; Cladribine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Middle Aged	1994
Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Antibodies; Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; Biopsy; Bone Marrow; Cladribine; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Leukocyte Common Antigens; Microscopy; Paraffin Embedding; Remission Induction; Spleen; Splenomegaly	1994
Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences). Acta haematologica Polonica, 1995, Volume: 26, Issue:2 Suppl 1 Topics: Adolescent; Adult; Aged; Blood Cell Count; Bone Marrow; Cladribine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Interferon-alpha; Interleukin-2; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Prognosis; Remission Induction; Splenectomy	1995
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:4 Topics: Adult; Aged; beta 2-Microglobulin; Bone Marrow; Cladribine; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Norway; Remission Induction	1995
Low-dose cladribine for symptomatic hairy cell leukaemia. British journal of haematology, 1995, Volume: 89, Issue:3 Topics: Adult; Aged; Cladribine; Dose-Response Relationship, Drug; Hemoglobins; Humans; Leukemia, Hairy Cell; Lymphocyte Count; Middle Aged; Opportunistic Infections; Platelet Count	1995
Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Adult; Cladribine; Humans; Israel; Leukemia, Hairy Cell; Middle Aged	1994
The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Cladribine; Double-Blind Method; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Pentostatin	1994
Retreatment with 2-CdA of progressed HCL patients. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Adult; Aged; Cladribine; Disease Progression; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged	1994
[Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine]. Ugeskrift for laeger, 1994, Apr-18, Volume: 156, Issue:16 Topics: Adult; Cladribine; Female; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Middle Aged	1994
Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin. Annals of internal medicine, 1993, Aug-15, Volume: 119, Issue:4 Topics: Adult; Cladribine; Drug Resistance; Female; Hematologic Tests; Humans; Immunophenotyping; Leukemia, Hairy Cell; Lymphocyte Subsets; Male; Middle Aged; Pentostatin; Remission Induction	1993
2-Chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in response in patients with and without abdominal lymphadenopathy. British journal of haematology, 1996, Volume: 93, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Lymphatic Diseases; Male; Middle Aged; Recurrence; Treatment Outcome	1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cladribine; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Immunologic Factors; Infections; Infusions, Intravenous; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Splenectomy; Treatment Outcome	1996
[Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group]. Nederlands tijdschrift voor geneeskunde, 1996, Aug-03, Volume: 140, Issue:31 Topics: Antineoplastic Agents; Cladribine; Combined Modality Therapy; Humans; Interferon-alpha; Leukemia, Hairy Cell; Remission Induction; Splenectomy	1996
Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood, 1996, Sep-15, Volume: 88, Issue:6 Topics: Adult; Aged; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Prognosis; Survival Analysis	1996
Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group. Japanese journal of clinical oncology, 1997, Volume: 27, Issue:3 Topics: Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neutropenia; Thrombocytopenia	1997
Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia. Recenti progressi in medicina, 1998, Volume: 89, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Cladribine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Middle Aged; Time Factors	1998
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Survival Analysis	1998
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Haematologica, 1999, Volume: 84, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cladribine; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infection Control; Interferon-alpha; Leukemia, Hairy Cell; Lymphopenia; Male; Middle Aged; Neutropenia; Pentostatin; Remission Induction; Treatment Outcome	1999
Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia. Blood, 1999, Apr-15, Volume: 93, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Drug Administration Schedule; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Recombinant Proteins	1999
Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine. Annals of hematology, 1999, Volume: 78, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Biopsy; Bone Marrow; Cladribine; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Recurrence; Remission Induction; Splenectomy; Survival Rate	1999
Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study. Seminars in oncology, 2000, Volume: 27, Issue:2 Suppl 5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Canada; Cause of Death; Cladribine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Interferon-alpha; Leukemia, Hairy Cell; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pentostatin; Remission Induction; Survival Rate; Treatment Outcome	2000
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. The New England journal of medicine, 2001, Jul-26, Volume: 345, Issue:4 Topics: Adult; Aged; Antibodies; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Resistance; Enterotoxins; Exotoxins; Female; Hemolytic-Uremic Syndrome; Humans; Immunotoxins; Leukemia, Hairy Cell; Male; Middle Aged; Pseudomonas; Recurrence; Remission Induction	2001
Hairy cell leukemia 1992. Leukemia, 1992, Volume: 6 Suppl 4 Topics: Cladribine; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin; Splenectomy	1992
Treatment of hairy-cell leukemia. Blood reviews, 1990, Volume: 4, Issue:4 Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy	1990

Other Studies

254 other study(ies) available for cladribine and Hairy Cell Leukemia

Article	Year
[Moxetumomab pasudotox-Third line in Hairy cell leukemia]. Bulletin du cancer, 2021, Volume: 108, Issue:12 Topics: Antineoplastic Agents; Bacterial Toxins; Cladribine; Exotoxins; Humans; Induction Chemotherapy; Leukemia, Hairy Cell; Pentostatin; Recurrence; Retreatment; Sialic Acid Binding Ig-like Lectin 2	2021
[Successful surgical resection of rectal cancer in a patient with relapsed hairy cell leukemia under interferon-α treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2021, Volume: 62, Issue:12 Topics: Aged, 80 and over; Antineoplastic Agents; Bone Marrow; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Rectal Neoplasms	2021
Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine. Annals of hematology, 2022, Volume: 101, Issue:5 Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Remission Induction; Retrospective Studies	2022
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia. Blood advances, 2022, 07-26, Volume: 6, Issue:14 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Remission Induction	2022
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study. Blood cancer journal, 2022, 07-19, Volume: 12, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult	2022
Long-term follow-up of patients with hairy cell leukemia in the south of Iran. Expert review of hematology, 2023, Volume: 16, Issue:4 Topics: Antineoplastic Agents; Cladribine; Follow-Up Studies; Humans; Iran; Leukemia, Hairy Cell; Remission Induction; Rituximab; Treatment Outcome	2023
COVID-19 in patients with classic and variant hairy cell leukemia. Blood advances, 2023, Dec-12, Volume: 7, Issue:23 Topics: Antineoplastic Agents; Cladribine; COVID-19; Female; Humans; Leukemia, Hairy Cell; Rituximab	2023
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia. Blood advances, 2023, 11-14, Volume: 7, Issue:21 Topics: Antibodies, Monoclonal; Cladribine; Humans; Leukemia, Hairy Cell; Rituximab; Salvage Therapy	2023
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up. Blood cancer journal, 2020, 05-27, Volume: 10, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Treatment Outcome	2020
Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features. Leukemia & lymphoma, 2020, Volume: 61, Issue:13 Topics: Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Rituximab	2020
Biotransformation of cladribine by a nanostabilized extremophilic biocatalyst. Journal of biotechnology, 2020, Nov-10, Volume: 323 Topics: Acrylic Resins; Antineoplastic Agents; Biosynthetic Pathways; Biotransformation; Cladribine; Deoxyadenosines; Extremophiles; Geobacillus; Leukemia, Hairy Cell; Nanocomposites; Temperature; Thermobifida	2020
First-Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia-Free Survival. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Consolidation Chemotherapy; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Rituximab	2021
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience. American journal of hematology, 2021, 10-01, Volume: 96, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Treatment Outcome	2021
Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol. Annals of hematology, 2017, Volume: 96, Issue:7 Topics: Aged; Allopurinol; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Eruptions; Drug Monitoring; Exanthema; Humans; Leukemia, Hairy Cell; Male; Pigmentation Disorders; Purpura; Severity of Illness Index; Treatment Outcome	2017
Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis. Journal of comparative effectiveness research, 2017, Volume: 6, Issue:6 Topics: Antineoplastic Agents; Cladribine; Databases, Factual; Female; Hospitalization; Humans; Insurance Claim Review; Leukemia, Hairy Cell; Male; Methotrexate; Middle Aged; Pentostatin; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome	2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population. Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Remission Induction; Retrospective Studies; SEER Program; Time Factors; Treatment Outcome; United States	2017
Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia? British journal of haematology, 2018, Volume: 183, Issue:1 Topics: Adult; Aged; Cladribine; Disease Management; Female; Humans; Immunophenotyping; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Pentostatin; Purines; Rituximab	2018
Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience. Turkish journal of haematology : official journal of Turkish Society of Haematology, 2017, Dec-01, Volume: 34, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies; Splenectomy; Treatment Outcome	2017
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report. Journal of medical case reports, 2018, Apr-24, Volume: 12, Issue:1 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Progression; Fatal Outcome; Humans; Janus Kinase 2; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukopenia; Male; Neutropenia; Oral Ulcer; Polycythemia Vera; Primary Myelofibrosis; Splenomegaly; Thrombocytopenia	2018
Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Antineoplastic Agents; Cladribine; Cohort Studies; Drug Eruptions; Drug Interactions; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Hairy Cell; Male; Middle Aged; Multivariate Analysis; Pentostatin; Retrospective Studies; Risk Assessment	2019
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel. Anticancer research, 2018, Volume: 38, Issue:11 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Early Detection of Cancer; Female; Humans; Injections, Subcutaneous; Israel; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies; Survival Analysis; Time-to-Treatment; Treatment Outcome; Young Adult	2018
Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia. International journal of dermatology, 2019, Volume: 58, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Cohort Studies; Cytarabine; Drug Eruptions; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Young Adult	2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia. Leukemia research, 2019, Volume: 82 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Cladribine; Female; Filgrastim; Humans; Israel; Length of Stay; Leukemia, Hairy Cell; Leukocyte Count; Male; Middle Aged; Neutrophils; Polyethylene Glycols; Pre-Exposure Prophylaxis; Retrospective Studies; Survival Analysis; Treatment Outcome	2019
Outcomes and second neoplasms in hairy cell leukemia: A retrospective cohort. Leukemia research, 2019, Volume: 83 Topics: Adult; Aged; Aged, 80 and over; Cladribine; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Rituximab; Splenectomy; Survival Rate	2019
High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing. Leukemia & lymphoma, 2019, Volume: 60, Issue:14 Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Australia; Case-Control Studies; Cladribine; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Prevalence; Prognosis; Retrospective Studies; Survival Rate; Vidarabine	2019
[Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:6 Topics: Antineoplastic Agents; Bone Marrow; Cladribine; Fatal Outcome; Humans; Leukemia, Hairy Cell; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections	2019
A rash in a hairy situation: Leukocytoclastic vasculitis at presentation of hairy cell Leukemia. American journal of hematology, 2019, Volume: 94, Issue:12 Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Cladribine; Female; Humans; Leukemia, Hairy Cell; Middle Aged; Paraneoplastic Syndromes; Remission Induction; Triamcinolone; Vasculitis, Leukocytoclastic, Cutaneous	2019
2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells. Clinical and experimental immunology, 2013, Volume: 173, Issue:2 Topics: Apoptosis; Caspase 3; Caspase 9; Cell Differentiation; Cells, Cultured; Cladribine; Dendritic Cells; DNA Damage; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Membrane Potential, Mitochondrial; Monocytes; Multiple Sclerosis; Tumor Suppressor Protein p53	2013
Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Resistance, Neoplasm; Flow Cytometry; Glutamic Acid; Humans; Indoles; Induction Chemotherapy; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Targeted Therapy; Point Mutation; Proto-Oncogene Proteins B-raf; Rituximab; Sulfonamides; Treatment Outcome; Valine; Vemurafenib	2013
Discrepant results for BRAF V600E mutation among different specimens in a case of hairy cell leukemia. Annals of laboratory medicine, 2013, Volume: 33, Issue:4 Topics: Antineoplastic Agents; Bone Marrow Cells; Cladribine; DNA Mutational Analysis; Female; Humans; Immunophenotyping; Leukemia, Hairy Cell; Middle Aged; Mutation; Proto-Oncogene Proteins B-raf; Reticulin	2013
Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC). Leukemia & lymphoma, 2014, Volume: 55, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Rituximab; Splenectomy; Treatment Outcome	2014
Outcomes of splenectomy versus cladribine for hairy cell leukemia in resource limited settings. Leukemia & lymphoma, 2014, Volume: 55, Issue:6 Topics: Antineoplastic Agents; Cladribine; Cost-Benefit Analysis; Developing Countries; Humans; Leukemia, Hairy Cell; Retrospective Studies; Splenectomy; Treatment Outcome	2014
Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series. Blood, 2014, Jan-09, Volume: 123, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Remission Induction; Retreatment; Treatment Outcome; Young Adult	2014
Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Dec-15, Volume: 19, Issue:24 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Rituximab; Treatment Outcome	2013
Hairy cell: young living longer but not cured. Blood, 2014, Jan-09, Volume: 123, Issue:2 Topics: Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male	2014
[IgA vasculitis revealing hairy cell leukemia relapse treated by cladribine]. Presse medicale (Paris, France : 1983), 2014, Volume: 43, Issue:3 Topics: Aged; Antineoplastic Agents; Cladribine; Diagnosis, Differential; Glomerulonephritis, IGA; Humans; Leukemia, Hairy Cell; Male; Neoplasm Recurrence, Local; Vasculitis, Leukocytoclastic, Cutaneous	2014
Left behind: should minimal residual disease be treated in hairy cell leukemia? Leukemia & lymphoma, 2014, Volume: 55, Issue:5 Topics: Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Pentostatin	2014
Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia. Acta haematologica, 2014, Volume: 132, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Cohort Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Hairy Cell; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Young Adult	2014
BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Dec-10, Volume: 32, Issue:35 Topics: Aged; Antineoplastic Agents; Cell Proliferation; Cladribine; Flow Cytometry; Histiocytic Sarcoma; Humans; Leukemia, Hairy Cell; Male; Mutation; Proto-Oncogene Proteins B-raf; Recurrence; Remission Induction	2014
Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related? The Journal of dermatology, 2014, Volume: 41, Issue:4 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Female; Humans; Hydroxychloroquine; Interferon-alpha; Leukemia, Hairy Cell; Panniculitis, Lupus Erythematosus; Rituximab	2014
Variant hairy cell leukemia following papillary urothelial neoplasm of bladder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2014, Volume: 24 Suppl 1 Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Transitional Cell; Cladribine; Flow Cytometry; Genetic Variation; Humans; Immunohistochemistry; Immunophenotyping; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Neoplasms, Second Primary; Treatment Outcome; Urinary Bladder Neoplasms	2014
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? Annals of hematology, 2014, Volume: 93, Issue:9 Topics: Adult; Aged; Cladribine; Female; Follow-Up Studies; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Neoadjuvant Therapy; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy; Treatment Outcome	2014
Hairy cell leukemia presenting initially with symptoms of Behçet's disease. International journal of rheumatic diseases, 2014, Volume: 17, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Behcet Syndrome; Biopsy; Cladribine; Diagnosis, Differential; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Male; Middle Aged; Oral Ulcer; Pancytopenia; Paraneoplastic Syndromes; Predictive Value of Tests; Prednisone; Scrotum; Skin Diseases; Treatment Outcome	2014
Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib. Annals of hematology, 2014, Volume: 93, Issue:12 Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Compassionate Use Trials; Drug Resistance, Neoplasm; Humans; Imidazoles; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Targeted Therapy; Mutation, Missense; Neoplasm Proteins; Neutropenia; Oximes; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pulmonary Aspergillosis; Remission Induction; Rituximab; Salvage Therapy; Splenectomy	2014
Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Mar-01, Volume: 34, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Diagnosis, Differential; Female; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Pentostatin; Proto-Oncogene Proteins B-raf; Rituximab; Splenectomy	2016
Second hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene. Leukemia & lymphoma, 2015, Volume: 56, Issue:3 Topics: Antigens, CD20; Antineoplastic Agents; Cladribine; DNA Mutational Analysis; Female; Hematologic Neoplasms; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins B-raf	2015
Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy. Hematological oncology, 2015, Volume: 33, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies; Survival Analysis; Turkey	2015
Specificity of treatment is mandatory in very old patients with hairy cell leukemia. Vojnosanitetski pregled, 2015, Volume: 72, Issue:5 Topics: Aged, 80 and over; Anemia; Antineoplastic Agents; Cladribine; Erythrocyte Transfusion; Humans; Leukemia, Hairy Cell; Male; Precision Medicine; Watchful Waiting	2015
Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine. The Korean journal of internal medicine, 2015, Volume: 30, Issue:5 Topics: Adult; Antineoplastic Agents; Biopsy; Cladribine; Humans; Leukemia, Hairy Cell; Male; Pyoderma Gangrenosum; Remission Induction; Time Factors; Treatment Outcome	2015
Cladribine Analogues via O⁶-(Benzotriazolyl) Derivatives of Guanine Nucleosides. Molecules (Basel, Switzerland), 2015, Oct-09, Volume: 20, Issue:10 Topics: Antineoplastic Agents; Cell Line, Tumor; Cladribine; Guanosine; Humans; Inhibitory Concentration 50; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphoma, T-Cell; Organophosphorus Compounds; Primary Cell Culture; Structure-Activity Relationship	2015
Hairy cell leukemia. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Disease Management; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Indoles; Leukemia, Hairy Cell; Male; Mutation; Pentostatin; Proto-Oncogene Proteins B-raf; Recurrence; Remission Induction; Sex Factors; Sulfonamides; Vemurafenib	2015
Interesting case of lymphocytosis and splenomegaly. BMJ (Clinical research ed.), 2016, Mar-03, Volume: 352 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Diagnosis, Differential; Female; Humans; Leukemia, Hairy Cell; Lymphocytosis; Rituximab; Splenomegaly; Treatment Outcome	2016
Excellent outcome of hairy cell leukaemia with extensive mesenteric infiltration following cladribine therapy. British journal of haematology, 2016, Volume: 174, Issue:5 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Lymphadenopathy; Male; Mesentery; Middle Aged; Neoplasm Invasiveness; Splenomegaly; Treatment Outcome	2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood, 2017, 02-02, Volume: 129, Issue:5 Topics: Antineoplastic Agents; Cladribine; Disease Management; Humans; Leukemia, Hairy Cell; Neoplasm Recurrence, Local; Neoplasm, Residual; Pentostatin; Treatment Outcome	2017
Cerebral tuberculomas in a patient with hairy cell leukaemia treated with cladribine. BMJ case reports, 2016, Dec-07, Volume: 2016 Topics: Aged; Antineoplastic Agents; Cladribine; Frontal Lobe; Humans; Leukemia, Hairy Cell; Magnetic Resonance Imaging; Male; Tuberculoma, Intracranial	2016
Hairy cell leukemia: treatment successes in the past 25 years. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jun-01, Volume: 26, Issue:16 Topics: Antineoplastic Agents; Cladribine; Enzyme Inhibitors; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Survival Analysis	2008
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Haematologica, 2008, Volume: 93, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Recurrence; Rituximab; Treatment Outcome	2008
Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine. Rheumatology (Oxford, England), 2008, Volume: 47, Issue:11 Topics: Cladribine; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Middle Aged; Paraneoplastic Syndromes; Scleroderma, Localized	2008
[50-year-old man with weight loss and splenomegaly]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:6 Topics: Antineoplastic Agents; B-Lymphocytes; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Lymphocyte Activation; Male; Middle Aged; Remission Induction; Splenomegaly; Weight Loss	2009
[Hairy cell leukemia in young patients]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:12 Topics: Adult; Age Factors; Antigens, CD; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Humans; Immunophenotyping; Interferon Type I; Leukemia, Hairy Cell; Lymphocytes; Male; Recombinant Proteins; Sex Factors; Splenectomy	2008
Rituximab in the treatment of the variant of hairy cell leukaemia: a case report. Prilozi, 2008, Volume: 29, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Middle Aged; Rituximab	2008
Has success spoiled hairy cell leukemia research? Key questions go unanswered, despite big gains. Journal of the National Cancer Institute, 2009, Mar-18, Volume: 101, Issue:6 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Biomedical Research; Bone Marrow; Cell Proliferation; Cladribine; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Interferons; Leukemia, Hairy Cell; Leukocyte Count; Leukocytes; Nucleosides; Pentostatin; Rituximab; Workforce	2009
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. British journal of haematology, 2009, Volume: 145, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Recurrence; Remission Induction; Rituximab; Survival Rate; Treatment Outcome	2009
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood, 2009, Nov-19, Volume: 114, Issue:21 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Complementarity Determining Regions; Female; Gene Rearrangement, B-Lymphocyte; Humans; Immunoglobulin Heavy Chains; Kaplan-Meier Estimate; Leukemia, Hairy Cell; Male; Middle Aged; Prognosis	2009
Hairy cell leukemia presenting as multiple discrete hepatic lesions. World journal of gastroenterology, 2009, Sep-21, Volume: 15, Issue:35 Topics: Antineoplastic Agents; Cladribine; Diagnosis, Differential; Humans; Leukemia, Hairy Cell; Liver; Liver Neoplasms; Male; Middle Aged; Organ Size; Treatment Outcome	2009
[Successful treatment of refractory hairy cell leukemia with rituximab]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2009, Aug-10, Volume: 98, Issue:8 Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Drug Resistance, Neoplasm; Humans; Leukemia, Hairy Cell; Male; Rituximab	2009
Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia. International journal of hematology, 2009, Volume: 90, Issue:4 Topics: Aged; Anemia, Aplastic; Anesthetics, Combined; Antilymphocyte Serum; Antineoplastic Agents; Asian People; Cladribine; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Pancytopenia; Treatment Outcome	2009
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood, 2010, Mar-11, Volume: 115, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Clinical Trials, Phase II as Topic; Databases, Factual; Drug Administration Schedule; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Remission Induction; Retrospective Studies; Survivors; Time Factors; Treatment Outcome	2010
Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom. Clinical therapeutics, 2009, Volume: 31 Pt 2 Topics: Antineoplastic Agents; Cladribine; Cost-Benefit Analysis; Humans; Leukemia, Hairy Cell; Models, Economic; Pentostatin; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom	2009
Diffuse osteosclerosis complicating hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, May-01, Volume: 28, Issue:13 Topics: Absorptiometry, Photon; Aged; Antineoplastic Agents; Bone Density; Bone Marrow Examination; Cladribine; Humans; Immunohistochemistry; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Osteoprotegerin; Osteosclerosis; Positron-Emission Tomography; Treatment Outcome	2010
Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:4 Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy	2011
The clinico-hematological profile of hairy cell leukaemia: a single centre experience. Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged	2010
Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:4 Topics: Amoxicillin; Anemia, Aplastic; Anti-Infective Agents; Antineoplastic Agents; Antiviral Agents; Aspergillosis; Bone Marrow; Ciprofloxacin; Cladribine; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Hairy Cell; Male; Oseltamivir; Pancytopenia; Pandemics; Pneumonia, Viral; Young Adult	2011
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome	2011
Molecular variant of hairy cell leukemia with poor prognosis. Leukemia & lymphoma, 2011, Volume: 52 Suppl 2 Topics: Cladribine; Gene Rearrangement; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Prognosis; Sequence Analysis, DNA; Treatment Outcome	2011
A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. The American journal of surgical pathology, 2011, Volume: 35, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclin D1; Cyclophosphamide; Doxorubicin; Drug Substitution; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Remission Induction; Translocation, Genetic; Treatment Failure; Vincristine; Withholding Treatment	2011
[Treatment of one hairy cell leukemia case with single course of cladribine]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:5 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male; Middle Aged	2011
[38-year-old patient with weight loss and night sweat. Hairy cell leukemia]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:41 Topics: Adult; Anemia; Antineoplastic Agents; Circadian Rhythm; Cladribine; Diagnosis, Differential; Humans; Hyperhidrosis; Leukemia, Hairy Cell; Leukocyte Count; Male; Platelet Count; Splenomegaly; Tomography, X-Ray Computed; Weight Loss	2011
High incidence of skin rash in patients with hairy cell leukemia treated with cladribine. Leukemia & lymphoma, 2012, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Exanthema; Female; Humans; Incidence; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult	2012
Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Feb-10, Volume: 30, Issue:5 Topics: Antineoplastic Agents; Biopsy; Cladribine; Female; Flow Cytometry; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Protein-Tyrosine Kinases; Pyrimidines	2012
My treatment approach to hairy cell leukemia. Mayo Clinic proceedings, 2012, Volume: 87, Issue:1 Topics: Antibiotic Prophylaxis; Antineoplastic Agents; Biopsy; Bone Marrow; Cladribine; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome	2012
Hairy Cell Leukemia and cutaneous involvement. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2012, Volume: 46, Issue:2 Topics: Antigens, CD; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male; Skin Neoplasms	2012
Treatment of hairy cell leukemia: long-term results in a developing country. Hematology (Amsterdam, Netherlands), 2012, Volume: 17, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Developing Countries; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Longitudinal Studies; Male; Mexico; Middle Aged; Recurrence; Remission Induction; Survival Analysis	2012
Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission. Journal of clinical and experimental hematopathology : JCEH, 2012, Volume: 52, Issue:1 Topics: Antineoplastic Agents; Cladribine; Fatal Outcome; Humans; Immunosuppression Therapy; Leukemia, Hairy Cell; Male; Meningoencephalitis; Middle Aged; Tuberculosis, Meningeal	2012
Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options. Clinical lymphoma, myeloma & leukemia, 2013, Volume: 13, Issue:1 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Administration Schedule; Female; Humans; Leukemia, Hairy Cell; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab	2013
[Treatment for recurrent hairy cell leukemia]. Terapevticheskii arkhiv, 2012, Volume: 84, Issue:7 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Recurrence; Remission Induction; Rituximab; Splenectomy	2012
Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine. Clinical and laboratory haematology, 2002, Volume: 24, Issue:4 Topics: Aged; Cladribine; Female; Humans; Leukemia, Hairy Cell; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vasculitis	2002
Successful treatment with 2-chlorodeoxyadenosine of secondary lesions of the central nervous system in low-grade lymphoid malignancies. American journal of hematology, 2002, Volume: 70, Issue:4 Topics: Central Nervous System Neoplasms; Cladribine; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasms, Second Primary; Treatment Outcome; Waldenstrom Macroglobulinemia	2002
[Pulmonary localization of hairy cell leukemia]. La Revue de medecine interne, 2002, Volume: 23, Issue:10 Topics: Aged; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Cladribine; Diagnosis, Differential; Female; Humans; Leukemia, Hairy Cell; Lung Neoplasms; Pneumonia; Radiography; Treatment Outcome	2002
Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient. Annals of hematology, 2002, Volume: 81, Issue:12 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Pentostatin; Recurrence; Remission Induction; Rituximab; Salvage Therapy	2002
Hairy cell leukemia with concurrent cryptococcus infection. American journal of hematology, 2003, Volume: 72, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cladribine; Cryptococcosis; Fluconazole; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction	2003
Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Mar-01, Volume: 21, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Interferons; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pentostatin; Remission Induction; Splenectomy; Survival Rate; Treatment Outcome	2003
Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Oncogene, 2003, Apr-17, Volume: 22, Issue:15 Topics: Antimetabolites, Antineoplastic; Apoptosis; B-Lymphocytes; Cell Adhesion; Cell Survival; Cladribine; Clone Cells; Culture Media; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Leukemia, Hairy Cell; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Neoplastic Cells, Circulating; Neoplastic Stem Cells; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; src-Family Kinases; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vitronectin	2003
Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia. Leukemia & lymphoma, 2003, Volume: 44, Issue:6 Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Humans; Hydroxyurea; Leukemia, Hairy Cell; Male; Thrombocythemia, Essential	2003
Hairy cell leukaemia with advanced treatment - a case report. Mymensingh medical journal : MMJ, 2003, Volume: 12, Issue:2 Topics: Adult; Antineoplastic Agents; Antitubercular Agents; Bone Marrow Examination; Cladribine; Humans; Leukemia, Hairy Cell; Male; Mycobacterium Infections; Remission Induction; Treatment Outcome	2003
Histological examination of the extrabulbar segment of the optic nerve in experimental animals after administration of Cladribine. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2002, Volume: 57, Issue:2 Topics: Animals; Cladribine; Dose-Response Relationship, Drug; Leukemia, Hairy Cell; Multiple Sclerosis; Optic Nerve; Optic Nerve Diseases; Rabbits	2002
Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2002, Volume: 57, Issue:2 Topics: Animals; Cladribine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Multiple Sclerosis; Rabbits; Reference Values; Retinal Degeneration; Retinal Ganglion Cells	2002
Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine). Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2002, Volume: 57, Issue:2 Topics: Animals; Cladribine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Rabbits; Reference Values; Retinal Ganglion Cells	2002
Histological examination of the lacrimal gland after experimental administration of Cladribine. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2002, Volume: 57, Issue:2 Topics: Animals; Cladribine; Dose-Response Relationship, Drug; Humans; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Leukemia, Hairy Cell; Multiple Sclerosis; Rabbits	2002
Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. British journal of haematology, 2003, Volume: 122, Issue:5 Topics: Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Eruptions; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies	2003
Disseminated zygomycosis: a rare cause of infection in patients with hematologic malignancies. The Journal of trauma, 2003, Volume: 55, Issue:3 Topics: Amphotericin B; Antineoplastic Agents; Cladribine; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Zygomycosis	2003
Hairy cell leukemia and sarcoidosis: a case report and review of the literature. Leukemia, 2003, Volume: 17, Issue:10 Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Humans; Leukemia, Hairy Cell; Male; Sarcoidosis; Treatment Outcome	2003
Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine. Blood, 2003, Nov-01, Volume: 102, Issue:9 Topics: Antineoplastic Agents; Cladribine; Epstein-Barr Virus Infections; Humans; Leukemia, Hairy Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasms, Second Primary	2003
Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia. Neoplasma, 2004, Volume: 51, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Primary Myelofibrosis	2004
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Haematologica, 2004, Volume: 89, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Treatment Outcome	2004
[Bone marrow fibrosis during therapy of hairy cell leukemia]. Ceskoslovenska patologie, 2004, Volume: 40, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Primary Myelofibrosis	2004
Successful pregnancy after cladribine therapy for hairy cell leukemia. Leukemia & lymphoma, 2004, Volume: 45, Issue:1 Topics: Adult; Cladribine; Female; Humans; Leukemia, Hairy Cell; Pregnancy; Time Factors	2004
[Hairy cell leukemia, Japanese variant, successfully treated with cladribine]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:5 Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male	2004
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:6 Topics: Antineoplastic Agents; Cladribine; Drug Administration Schedule; Erythema Nodosum; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pancytopenia; Primary Myelofibrosis; Remission Induction; Splenomegaly	2004
An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Leukemia, 2004, Volume: 18, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Cohort Studies; Female; Follow-Up Studies; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Second Primary; Palliative Care; Pentostatin; Splenectomy; Survival Rate; Treatment Outcome	2004
Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia. Leukemia & lymphoma, 2004, Volume: 45, Issue:5 Topics: Aged; Cladribine; Fatal Outcome; Herpesvirus 4, Human; Humans; Immunohistochemistry; Immunosuppressive Agents; Leukemia, Hairy Cell; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary	2004
Wrist tuberculosis in cladribine--induced remission of hairy cell leukosis. Folia medica, 2000, Volume: 42, Issue:4 Topics: Antitubercular Agents; Biopsy, Needle; Cladribine; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Male; Middle Aged; Opportunistic Infections; Remission Induction; Risk Assessment; Tuberculosis, Osteoarticular; Wrist Joint	2000
Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5 Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Drug Resistance, Neoplasm; Humans; Immunization, Passive; Interferon-alpha; Leukemia, Hairy Cell; Recurrence; Remission Induction; Rituximab; Splenectomy	2004
Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant. International journal of hematology, 2004, Volume: 80, Issue:5 Topics: Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Drug Therapy, Combination; Humans; Japan; Leukemia, Hairy Cell; Male; Pentostatin; Remission Induction; Rituximab	2004
Hairy cell leukemia: clinical presentation and long term follow up after treatment with 2-chlorodeoxyadenosine (2-CdA). JPMA. The Journal of the Pakistan Medical Association, 2005, Volume: 55, Issue:5 Topics: Adult; Antineoplastic Agents; Bone Marrow Neoplasms; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies; Splenic Neoplasms; Time Factors	2005
Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide. Leukemia research, 2005, Volume: 29, Issue:8 Topics: Aged; Cladribine; Humans; Leukemia, Hairy Cell; Male; Primary Myelofibrosis; Remission Induction; Thalidomide; Treatment Outcome	2005
Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia. Leukemia & lymphoma, 2005, Volume: 46, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Hodgkin Disease; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Pentostatin	2005
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer, 2005, Dec-01, Volume: 104, Issue:11 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Pentostatin; Retrospective Studies; Splenectomy; Survival Analysis; Time Factors	2005
Development of hairy cell leukemia in a patient after cardiac transplantation. Leukemia & lymphoma, 2006, Volume: 47, Issue:2 Topics: Antineoplastic Agents; Cladribine; Flow Cytometry; Heart Transplantation; Humans; Leukemia, B-Cell; Leukemia, Hairy Cell; Male; Middle Aged; Myocardial Ischemia; Remission Induction; Sensitivity and Specificity	2006
Concomitant hairy cell and acute myeloid leukemia. European journal of haematology, 2006, Volume: 76, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Daunorubicin; Genetic Predisposition to Disease; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Stem Cell Transplantation	2006
[Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:11 Topics: Adult; Antineoplastic Agents; Cladribine; Female; Humans; Injections, Intravenous; Leukemia, Hairy Cell; Neutropenia; Remission Induction; Time Factors	2005
Cryptococcus neoformans meningitis in a patient with hairy cell leukemia. American journal of hematology, 2006, Volume: 81, Issue:5 Topics: Adult; Antineoplastic Agents; Cladribine; Cryptococcus neoformans; Humans; Leukemia, Hairy Cell; Lymphopenia; Male; Meningitis, Cryptococcal; Opportunistic Infections; Treatment Outcome	2006
[Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine]. Arerugi = [Allergy], 2006, Volume: 55, Issue:6 Topics: Adult; Antineoplastic Agents; Cladribine; Drug Hypersensitivity; Humans; Leukemia, Hairy Cell; Male	2006
Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin. Prescrire international, 2006, Volume: 15, Issue:84 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy	2006
Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment. Leukemia research, 2007, Volume: 31, Issue:6 Topics: Aged; Cladribine; Demyelinating Autoimmune Diseases, CNS; Gene Expression Regulation, Leukemic; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Light Chains; Immunoglobulin M; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Myelin-Associated Glycoprotein; Paraproteinemias; Remission Induction	2007
Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10 Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cladribine; Cytomegalovirus; Dexamethasone; Esophagitis; Female; Giant Cell Arteritis; Herpes Simplex; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukemia, Hairy Cell; Methylprednisolone; Opportunistic Infections; Pneumocystis carinii; Trimethoprim, Sulfamethoxazole Drug Combination	2006
Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report. Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blood Transfusion; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Rituximab; Salvage Therapy	2006
Hairy-cell leukemia: a rare blood disorder in Asia. The Southeast Asian journal of tropical medicine and public health, 2006, Volume: 37 Suppl 3 Topics: Aged; Antineoplastic Agents; Cladribine; Diagnosis, Differential; Humans; Leukemia, Hairy Cell; Malaysia; Male	2006
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia. Cancer, 2007, Nov-15, Volume: 110, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Recurrence; Rituximab	2007
[Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:11 Topics: Aged; Antineoplastic Agents; Cladribine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Radiography, Abdominal; Remission Induction; Tomography, X-Ray Computed	2007
Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia. Leukemia & lymphoma, 2007, Volume: 48, Issue:12 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Resistance, Neoplasm; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Leukemia, Hairy Cell; Male; Middle Aged; Rituximab	2007
Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases. Journal of the Chinese Medical Association : JCMA, 2007, Volume: 70, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Splenectomy	2007
Cross-resistance to purine analogs in hairy cell leukemia. Annals of internal medicine, 1994, Feb-01, Volume: 120, Issue:3 Topics: Antimetabolites, Antineoplastic; Cladribine; Drug Resistance; Humans; Leukemia, Hairy Cell; Pentostatin; Vidarabine Phosphate	1994
Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia. American journal of hematology, 1995, Volume: 49, Issue:3 Topics: Anemia; Cladribine; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Hairy Cell; Middle Aged; Recombinant Proteins; Religion	1995
Optimal treatment for untreated patients with hairy cell leukemia? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10 Topics: Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Splenectomy; Survival Rate	1995
Mechanisms behind hypocholesterolaemia in hairy cell leukaemia. BMJ (Clinical research ed.), 1995, Jul-01, Volume: 311, Issue:6996 Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cladribine; Humans; Leukemia, Hairy Cell; Receptors, LDL; Triglycerides	1995
Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:4 Topics: Cladribine; Female; Fever; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Risk Factors; T-Lymphocyte Subsets	1995
Effectiveness of 2-chlorodeoxyadenosine in nodal and extra haematopoietic localizations in hairy cell leukaemia. European journal of haematology, 1995, Volume: 55, Issue:2 Topics: Bone Marrow; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged	1995
Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report. Connecticut medicine, 1995, Volume: 59, Issue:6 Topics: Aged; Cladribine; Drug Administration Schedule; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Uric Acid	1995
2-Chlorodeoxyadenosine in psoriasis treatment. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Psoriasis; Remission Induction	1995
Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood, 1993, Sep-15, Volume: 82, Issue:6 Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Biomarkers, Tumor; Biopsy; Bone Marrow; Cladribine; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Leukocyte Common Antigens; T-Lymphocytes; Time Factors	1993
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report. Cancer, 1995, Apr-15, Volume: 75, Issue:8 Topics: Aged; Aged, 80 and over; Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Neoplasms, Second Primary; Splenectomy	1995
Hairy cell leukemia: treatment results and association with secondary malignancy. American journal of hematology, 1995, Volume: 48, Issue:4 Topics: China; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Melanoma; Neoplasms, Second Primary	1995
Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2 Topics: Blotting, Western; Cladribine; Colonic Neoplasms; Deoxycytidine Kinase; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Sarcoma; Stomach Neoplasms; Tissue Distribution; Tumor Cells, Cultured	1995
Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia, 1995, Volume: 9, Issue:5 Topics: Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cladribine; Follow-Up Studies; Humans; Interferon Type I; Leukemia, Hairy Cell; Male; Middle Aged; Recombinant Proteins; T-Lymphocytopenia, Idiopathic CD4-Positive	1995
Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Bone Marrow; Cladribine; Clone Cells; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphocytes; Phenotype; Remission Induction	1994
Incidence and significance of abdominal lymphadenopathy in hairy cell leukaemia. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Abdomen; Adult; Aged; Aged, 80 and over; Cladribine; Female; Humans; Incidence; Leukemia, Hairy Cell; Lymphatic Diseases; Male; Middle Aged; Pentostatin; Time Factors; Tomography, X-Ray Computed	1994
Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Adult; Aged; Biopsy; Bone Marrow; Cladribine; Female; Humans; Immunohistochemistry; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Time Factors	1994
Treatment of hairy cell leukemia in a decade of change. Appraisal of community based oncologists' opinions. Leukemia & lymphoma, 1994, Volume: 14 Suppl 1 Topics: Attitude of Health Personnel; Cladribine; Community Medicine; Connecticut; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Medical Oncology; New Jersey; New York; Pentostatin; Practice Patterns, Physicians'; Splenectomy	1994
Do we know the treatment of choice for hairy cell leukemia? Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:8 Topics: Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Remission Induction	1994
2-Chlorodeoxyadenosine treatment in hairy cell leukemia. Annals of internal medicine, 1994, Jan-15, Volume: 120, Issue:2 Topics: Cladribine; Humans; Leukemia, Hairy Cell; Remission Induction	1994
Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia. European journal of haematology, 1994, Volume: 52, Issue:1 Topics: Adult; Aged; Cladribine; Female; Humans; Immunity, Cellular; Immunophenotyping; Killer Cells, Natural; Leukemia, Hairy Cell; Lymphocyte Subsets; Male; Middle Aged	1994
Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cladribine; Female; Humans; Leukemia, Hairy Cell; Lymph Nodes; Lymphatic Diseases; Male; Middle Aged; Prospective Studies; Splenectomy; Tomography, X-Ray Computed; Treatment Outcome	1994
High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Leukemia & lymphoma, 1993, Volume: 11, Issue:5-6 Topics: Adult; Aged; Bone Marrow; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Receptors, Interleukin-2	1993
2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood, 1994, May-15, Volume: 83, Issue:10 Topics: CD4-Positive T-Lymphocytes; Cladribine; Humans; Leukemia, Hairy Cell; Leukocyte Count; T-Lymphocyte Subsets	1994
Managing hairy cell leukemia in pregnancy. Annals of internal medicine, 1994, Jun-15, Volume: 120, Issue:12 Topics: Adult; Cladribine; Female; Humans; Leukemia, Hairy Cell; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome	1994
Bone marrow granulomas in hairy cell leukaemia following 2-chlorodeoxyadenosine therapy. Histopathology, 1994, Volume: 24, Issue:3 Topics: Adult; Bone Marrow; Bone Marrow Diseases; Cladribine; Granuloma; Humans; Leukemia, Hairy Cell; Male	1994
Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood, 1994, Jun-15, Volume: 83, Issue:12 Topics: Adult; Aged; Antigens, CD; Bone Marrow; Cladribine; Female; Flow Cytometry; Humans; Leukemia, Hairy Cell; Lymphocyte Subsets; Male; Middle Aged; Phenotype	1994
[Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1994, Mar-10, Volume: 114, Issue:7 Topics: Adult; Aged; Cladribine; Female; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Middle Aged; Prognosis; Time Factors	1994
A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia, 1994, Volume: 8, Issue:7 Topics: Aged; Base Sequence; Blotting, Southern; Cladribine; Drug Administration Schedule; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Remission Induction; Risk Factors	1994
Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections. Leukemia, 1994, Volume: 8, Issue:9 Topics: Adult; Aged; Cladribine; Disease Susceptibility; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Opportunistic Infections; Remission Induction; Splenectomy; T-Lymphocyte Subsets	1994
Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia, 1994, Volume: 8, Issue:11 Topics: Cladribine; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Leukemia, Hairy Cell; Neoplasm, Residual	1994
Cladribine (Leustatin). Single-dose treatment for leukemia. The American journal of nursing, 1994, Volume: 94, Issue:11 Topics: Cladribine; Humans; Leukemia, Hairy Cell	1994
Criteria for use of cladribine in adults. American journal of hospital pharmacy, 1994, Sep-01, Volume: 51, Issue:17 Topics: Adult; Cladribine; Female; Humans; Leukemia; Leukemia, Hairy Cell; Treatment Outcome	1994
Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients. British journal of haematology, 1994, Volume: 87, Issue:4 Topics: Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic, T-Cell; Leukocytes, Mononuclear; Phosphorylation	1994
Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood, 1994, Dec-15, Volume: 84, Issue:12 Topics: Antibodies, Monoclonal; Antibody Specificity; Avidin; B-Lymphocyte Subsets; Biopsy, Needle; Biotin; Bone Marrow; Bone Marrow Examination; Cell Membrane; Cell Nucleus; Cladribine; Cytoplasmic Granules; False Negative Reactions; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Neoplasm, Residual; Neoplastic Stem Cells; Remission Induction	1994
Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood, 1993, Feb-01, Volume: 81, Issue:3 Topics: 5'-Nucleotidase; Aged; Antigens, CD; Cladribine; Cytoplasm; Deoxycytidine Kinase; False Positive Reactions; Female; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prognosis; Tumor Cells, Cultured	1993
Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation. Blood, 1993, Apr-01, Volume: 81, Issue:7 Topics: Cell Division; Cladribine; Cytotoxicity, Immunologic; Drug Synergism; Drug Therapy, Combination; Humans; Immunity, Cellular; Interferon Type I; Interferon-alpha; Interleukin-2; Killer Cells, Natural; Leukemia, Hairy Cell; Lymphocyte Activation; Major Histocompatibility Complex; Recombinant Proteins; Tumor Cells, Cultured	1993
[Complete remission in a patient with hairy cell leukemia after treatment with 2-chlorodeoxyadenosine]. Acta haematologica Polonica, 1993, Volume: 24, Issue:1 Topics: Adult; Cladribine; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Remission Induction	1993
New drug bulletin. Cladribine injection (leustatin). RN, 1994, Volume: 57, Issue:3 Topics: Adult; Child; Cladribine; Drug Interactions; Female; Humans; Leukemia, Hairy Cell; Patient Education as Topic; Pregnancy	1994
Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine. American journal of ophthalmology, 1996, Volume: 121, Issue:1 Topics: Aged; Antineoplastic Agents; B-Lymphocytes; Cladribine; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Retinal Diseases; Uveitis	1996
Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia. British journal of haematology, 1996, Volume: 92, Issue:2 Topics: Adult; Cladribine; Eosinophils; Flow Cytometry; Humans; Hypereosinophilic Syndrome; Interleukin-5; Leukemia, Hairy Cell; Male; Receptors, Interleukin-2	1996
Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood, 1996, Feb-15, Volume: 87, Issue:4 Topics: Antibodies, Monoclonal; Antigens, CD20; Antimetabolites, Antineoplastic; Bone Marrow; Cladribine; Humans; Immunochemistry; Leukemia, Hairy Cell; Neoplasm, Residual; Prognosis; Time Factors	1996
Disease-related hypocholesterolemia in patients with hairy cell leukemia. Positive correlation with spleen size but not with tumor cell burden or low density lipoprotein receptor activity. Cancer, 1995, Aug-01, Volume: 76, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cholesterol; Cladribine; Dyslipidemias; Female; Humans; Leukemia, Hairy Cell; Lipids; Male; Middle Aged; Receptors, LDL; Spleen	1995
[Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment]. Acta haematologica Polonica, 1996, Volume: 27, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Cladribine; Female; Fibrosis; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction	1996
Infectious complications after 2-chlorodeoxyadenosine therapy. European journal of haematology, 1996, Volume: 56, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Cohort Studies; Disease Susceptibility; Female; Fever; Hematologic Diseases; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Incidence; Infections; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Waldenstrom Macroglobulinemia	1996
Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness? American journal of hematology, 1996, Volume: 53, Issue:1 Topics: Anemia; Antineoplastic Agents; Blood Transfusion; Christianity; Cladribine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Hairy Cell; Opportunistic Infections; Treatment Refusal	1996
Panuveitis responsive to 2-CdA: an unusual ocular presentation of hairy cell leukemia. Leukemia & lymphoma, 1996, Volume: 20, Issue:5-6 Topics: Aged; Antimetabolites, Antineoplastic; Cladribine; Humans; Leukemia, Hairy Cell; Male; Panuveitis; Paraneoplastic Syndromes; Remission Induction	1996
Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Blood cells, molecules & diseases, 1995, Volume: 21, Issue:2 Topics: Adult; Antineoplastic Agents; Bone Marrow; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual	1995
Bone marrow granulomas in hairy cell leukaemia. Histopathology, 1996, Volume: 29, Issue:3 Topics: Bone Marrow Diseases; Cladribine; Granuloma; Humans; Leukemia, Hairy Cell; Male; Middle Aged	1996
Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta dermato-venereologica, 1996, Volume: 76, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Cladribine; Drug Eruptions; Female; Humans; Leukemia, Hairy Cell; Lymphopenia; Male; Middle Aged; Retrospective Studies	1996
Halogenoderma of the forearm caused by 2-chlorodeoxyadenosine treatment. American journal of hematology, 1996, Volume: 53, Issue:3 Topics: Adult; Antimetabolites, Antineoplastic; Chlorine; Cladribine; Drug Eruptions; Forearm; Humans; Hyperplasia; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Necrosis; Skin	1996
Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia. Neoplasma, 1996, Volume: 43, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cladribine; Cohort Studies; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Receptors, Interleukin-2	1996
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications. Blood, 1997, Mar-01, Volume: 89, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Communicable Diseases; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Middle Aged	1997
Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Disease Progression; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Phenotype; Recurrence; Remission Induction	1997
T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine. Acta haematologica, 1997, Volume: 97, Issue:3 Topics: Antineoplastic Agents; Cladribine; Female; Humans; Immunity, Cellular; Immunosuppressive Agents; Killer Cells, Natural; Leukemia, Hairy Cell; Male; Middle Aged; T-Lymphocytes	1997
Molecular study of hairy cell leukemia variant with biclonal paraproteinemia. Archives of pathology & laboratory medicine, 1997, Volume: 121, Issue:2 Topics: Aged; Antineoplastic Agents; Blotting, Southern; Bone Marrow Cells; Cladribine; DNA; Gene Rearrangement; Humans; Immunoelectrophoresis; Immunoglobulin kappa-Chains; Immunoglobulins; Immunophenotyping; Leukemia, Hairy Cell; Leukocytes, Mononuclear; Male; Paraproteinemias	1997
Second cancer risk in hairy cell leukemia: analysis of 350 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Incidence; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Pentostatin; Referral and Consultation; Survival Analysis	1997
Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases. Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4 Topics: Aged; Antigens, Surface; Antineoplastic Agents; Cladribine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Recurrence; Remission Induction; Spleen; Treatment Outcome	1997
[Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF]. Medicina, 1996, Volume: 56, Issue:5 Pt 1 Topics: Adult; Antineoplastic Agents; Cladribine; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Hairy Cell; Male; Middle Aged	1996
Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity. American journal of hematology, 1997, Volume: 55, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Cell Division; Cholesterol; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Invasiveness; Splenomegaly	1997
Transient acantholytic dermatosis after treatment with 2-chlorodeoxyadenosine. Acta dermato-venereologica, 1997, Volume: 77, Issue:5 Topics: Acantholysis; Adenosine Triphosphate; Cladribine; Drug Eruptions; Enzyme Inhibitors; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies	1997
The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Leukemia & lymphoma, 1997, Volume: 26, Issue:3-4 Topics: Adult; Antineoplastic Agents; Cladribine; Heart Failure; Humans; Leukemia, Hairy Cell; Male	1997
Treatment of hairy cell leukaemia (HCL) with 2-chlorodeoxyadenosine (2-CdA): identification of parameters predictive of adverse effects. British journal of haematology, 1997, Volume: 99, Issue:1 Topics: Antineoplastic Agents; Blood Transfusion; Cladribine; Female; Humans; Interferons; Leukemia, Hairy Cell; Male; Neutropenia	1997
Long-term results in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Acta medica (Hradec Kralove), 1997, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Receptors, Interleukin-2	1997
Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment. Annals of hematology, 1998, Volume: 76, Issue:1 Topics: Annexin A5; Apoptosis; Cladribine; Flow Cytometry; Humans; Injections, Intravenous; Leukemia, Hairy Cell; Lymphocyte Count; Lymphocyte Subsets; Lymphocytes; Recurrence	1998
Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:2 Topics: Acid Phosphatase; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bryostatins; Cell Division; Cladribine; DNA, Neoplasm; Drug Administration Schedule; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lipid Metabolism; Macrolides; Male; Mice; Mice, SCID; Neoplasm Proteins; Neoplasm Transplantation; Spectroscopy, Fourier Transform Infrared; Transplantation, Heterologous; Tumor Cells, Cultured	1998
Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience. Blood, 1998, Aug-15, Volume: 92, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; British Columbia; Cladribine; Combined Modality Therapy; Comorbidity; Female; Humans; Immunologic Factors; Incidence; Interferons; Leukemia, Hairy Cell; Life Tables; Male; Middle Aged; Neoplasms, Second Primary; Pentostatin; Prospective Studies; Risk; Smoking; Splenectomy	1998
Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood, 1998, Sep-15, Volume: 92, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Interferons; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pentostatin; Remission Induction; Splenectomy; Survival Analysis; Treatment Failure	1998
Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia. European journal of haematology, 1998, Volume: 61, Issue:4 Topics: Antineoplastic Agents; Cladribine; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Meningitis, Cryptococcal; Middle Aged	1998
Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine. Neoplasma, 1998, Volume: 45, Issue:4 Topics: Adult; Aged; Anemia, Sideroblastic; Antimetabolites, Antineoplastic; Bone Marrow; Cladribine; Combined Modality Therapy; Erythrocyte Indices; Erythrocytes, Abnormal; Erythropoiesis; Female; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Splenectomy; Treatment Outcome	1998
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. European journal of haematology, 1999, Volume: 62, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Cohort Studies; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Neutropenia; Poland; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome	1999
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Cancer, 1999, Jan-01, Volume: 85, Issue:1 Topics: Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction	1999
2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients. The American Journal of dermatopathology, 1999, Volume: 21, Issue:1 Topics: Acantholysis; Antineoplastic Agents; Cladribine; Drug Eruptions; Humans; Leukemia, Hairy Cell	1999
[Failure of treatment with 2-chlorodeoxyadenosine in the course of hairy cell leukemia associated with malignant histiocytosis]. La Revue de medecine interne, 1999, Volume: 20, Issue:3 Topics: Adult; Antineoplastic Agents; Cladribine; Histiocytic Sarcoma; Humans; Leukemia, Hairy Cell; Male; Treatment Failure	1999
An otherwise typical case of non-Japanese hairy cell leukemia with CD10 and CDw75 expression: response to cladaribine phosphate therapy. Journal of clinical laboratory analysis, 1999, Volume: 13, Issue:4 Topics: Antigens, CD; Antineoplastic Agents; Cladribine; Humans; Immunoenzyme Techniques; Leukemia, Hairy Cell; Middle Aged; Neprilysin; Pancytopenia; Sialyltransferases	1999
Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia. Blood, 1999, Aug-01, Volume: 94, Issue:3 Topics: Aged; Aged, 80 and over; Antigens, CD19; Antineoplastic Agents; Apoptosis; Cladribine; Female; Fibroblast Growth Factor 2; Humans; Integrin alphaXbeta2; Leukemia, Hairy Cell; Male; Middle Aged	1999
Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadenosine for hairy cell leukemia. Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:2 Pt 2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Hairy Cell; Male; Psoriasis	1999
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow; Cladribine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Pentostatin; Recurrence; Remission Induction	1999
Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment. Leukemia, 1999, Volume: 13, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cladribine; Female; Humans; Leukemia, Hairy Cell; Leukocyte Common Antigens; Male; Middle Aged; Pregnancy; Time Factors	1999
Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine. British journal of haematology, 1999, Volume: 106, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Recurrence; Survival Analysis	1999
Technetium-99m sulfur colloid scanning and correlative magnetic resonance imaging in patients with hairy cell leukemia and hypocellular bone marrow biopsies after 2-chlorodeoxyadenosine. Leukemia & lymphoma, 1999, Volume: 35, Issue:1-2 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Cells; Cell Count; Cladribine; Humans; Leukemia, Hairy Cell; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Technetium Tc 99m Sulfur Colloid	1999
Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis. Acta haematologica, 1999, Volume: 102, Issue:2 Topics: Antineoplastic Agents; Cladribine; Disease Progression; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Multiple Sclerosis	1999
Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia. British journal of haematology, 1999, Volume: 105, Issue:4 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin	1999
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment. Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Marrow; CD4 Lymphocyte Count; Cladribine; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infections; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Opportunistic Infections; Pentostatin; Remission Induction; Splenectomy; Survival Rate	1999
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Wiener klinische Wochenschrift, 1999, Dec-23, Volume: 111, Issue:24 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Data Interpretation, Statistical; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Recurrence; Remission Induction; Splenectomy; Time Factors	1999
Treatment of hairy cell leukemia-variant with cladribine. Leukemia & lymphoma, 1999, Volume: 35, Issue:3-4 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Middle Aged; Splenectomy; Treatment Outcome	1999
Mycobacterium-avium-intracellulare complex infection following 2-chlorodeoxyadenosine therapy for hairy cell leukaemia. Leukemia & lymphoma, 2000, Volume: 36, Issue:5-6 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Cladribine; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prednisone	2000
Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. Clinical and laboratory haematology, 2000, Volume: 22, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cladribine; Disseminated Intravascular Coagulation; Erythema; Erythema Multiforme; Humans; Leukemia, Hairy Cell; Male	2000
New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine. Acta haematologica, 2000, Volume: 103, Issue:2 Topics: Antimetabolites, Antineoplastic; B-Lymphocytes; Blotting, Southern; Cladribine; Clone Cells; Gene Rearrangement, B-Lymphocyte; Genes, Immunoglobulin; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm, Residual; Neoplastic Stem Cells; Remission Induction	2000
Test and teach. Number one hundred and one: Part 1. Pathology, 2000, Volume: 32, Issue:2 Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Diagnosis, Differential; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Hairy Cell; Leukemic Infiltration; Lymphoma; Male; Splenectomy; Splenic Neoplasms; Treatment Outcome	2000
Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine. Leukemia research, 2000, Volume: 24, Issue:7 Topics: Acute Disease; Aged; Antineoplastic Agents; Blood Cell Count; Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid; Male; Neoplasms, Second Primary	2000
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Haematologica, 2000, Volume: 85, Issue:9 Topics: Adult; Aged; Cladribine; Disease-Free Survival; Drug Evaluation; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Recurrence; Survival Rate; Treatment Outcome	2000
CD5+ immunophenotype in the bone marrow but not in the peripheral blood in a patient with hairy cell leukemia. Acta haematologica, 2000, Volume: 103, Issue:4 Topics: Adult; B-Lymphocytes; Bone Marrow; CD5 Antigens; Cladribine; Clone Cells; Humans; Immunophenotyping; Leukemia, Hairy Cell; Male; Remission Induction	2000
Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy. European journal of haematology, 2001, Volume: 66, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Blood Cell Count; Bone Marrow Diseases; Bone Marrow Examination; Cladribine; Combined Modality Therapy; Follow-Up Studies; Hematopoiesis; Humans; Interferons; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Remission Induction; Splenectomy	2001
[Hairy cell leukemia. An alternative method for the detection of minimal residual disease using flow cytometry]. Medicina, 2000, Volume: 60 Suppl 2 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Case-Control Studies; Cladribine; Flow Cytometry; Follow-Up Studies; Humans; Immunohistochemistry; Interferon-alpha; Leukemia, Hairy Cell; Neoplasm, Residual; Remission Induction; Sensitivity and Specificity	2000
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 2001, Volume: 64, Issue:1 Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male; Middle Aged	2001
Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia. Leukemia & lymphoma, 2000, Volume: 39, Issue:5-6 Topics: Aged; Autoantibodies; Cladribine; G(M1) Ganglioside; Gangliosides; Guillain-Barre Syndrome; Humans; Leukemia, Hairy Cell; Male	2000
[Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine]. Vnitrni lekarstvi, 2000, Volume: 46, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Female; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukemic Infiltration; Male; Middle Aged; Neoplasm, Residual; Remission Induction	2000
Purpuric rash following treatment with 2-chlorodeoxyadenosine. Clinical and laboratory haematology, 2001, Volume: 23, Issue:1 Topics: Aged; Aged, 80 and over; Cladribine; Exanthema; Humans; Leukemia, Hairy Cell; Male	2001
The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells. American journal of hematology, 2001, Volume: 67, Issue:4 Topics: Adult; Aged; Antigens, CD; Antineoplastic Agents; Biomarkers; Cladribine; Female; Flow Cytometry; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Male; Middle Aged; Neoplastic Cells, Circulating; Thrombocytopenia; Treatment Outcome	2001
Sin of omission? Pharmaceutical trade group failed to disclose that ad subject was employee. Modern healthcare, 2001, Aug-06, Volume: 31, Issue:32 Topics: Advertising; Cladribine; Conflict of Interest; Drug Industry; Humans; Information Services; Leukemia, Hairy Cell; Male; Middle Aged; United States	2001
Gynecomastia in a case of hairy cell leukaemia--cladribine induced? Leukemia & lymphoma, 2001, Volume: 42, Issue:1-2 Topics: Adult; Cladribine; Gynecomastia; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Mammography	2001
Treatment of hairy-cell leukemia. The New England journal of medicine, 2001, Nov-15, Volume: 345, Issue:20 Topics: Antibodies; Antineoplastic Agents; Cladribine; Drug Resistance; Enterotoxins; Humans; Immunotoxins; Leukemia, Hairy Cell; Remission Induction	2001
Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases. Haematologica, 2002, Volume: 87, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Cladribine; Combined Modality Therapy; Drug Evaluation; Female; Follow-Up Studies; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Salvage Therapy; Splenectomy; Treatment Outcome	2002
Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. Neoplasma, 2001, Volume: 48, Issue:5 Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; B-Lymphocytes; Blood Cells; Bone Marrow Cells; CD4 Antigens; Cell Adhesion Molecules; Cladribine; Female; Flow Cytometry; Humans; Immunophenotyping; Integrin alpha Chains; Interferon-alpha; Lectins; Leukemia, Hairy Cell; Lymphocyte Subsets; Macrophage-1 Antigen; Male; Middle Aged; Phenotype; Receptors, Interleukin-2; Sialic Acid Binding Ig-like Lectin 2	2001
Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia. British journal of haematology, 2002, Volume: 116, Issue:3 Topics: Adult; Aged; Antigen Presentation; Antineoplastic Agents; Cell Count; Cladribine; Dendritic Cells; Flow Cytometry; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Middle Aged	2002
Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failure. Leukemia & lymphoma, 2002, Volume: 43, Issue:2 Topics: Cladribine; Humans; Infusions, Parenteral; Leukemia, Hairy Cell; Male; Medication Errors; Middle Aged; Treatment Failure	2002
[Hairy cell leukemia treated with cladribine]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002, Apr-30, Volume: 122, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prospective Studies; Remission Induction; Treatment Outcome	2002
[Therapeutic effectiveness of cladribine and cellular immunodeficiency--related effects in hairy-cell leukemia?]. Vnitrni lekarstvi, 2002, Volume: 48, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; CD4 Lymphocyte Count; CD56 Antigen; CD8-Positive T-Lymphocytes; Cladribine; Disease Progression; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Lymphocytes; Male; Middle Aged; Recurrence; Remission Induction	2002
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections. Blood, 1992, Feb-15, Volume: 79, Issue:4 Topics: 2-Chloroadenosine; Antineoplastic Agents; Candidiasis; Cladribine; Cytomegalovirus Infections; Deoxyadenosines; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Lymphocytes; Monocytes; Neutrophils; Opportunistic Infections; Remission Induction; Thrombocytopenia	1992
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood, 1992, Feb-15, Volume: 79, Issue:4 Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Drug Resistance; Humans; Leukemia, Hairy Cell; Leukocyte Count; Leukopenia; Male; Middle Aged; Neutrophils; Platelet Count; Remission Induction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory	1992
[Alpha interferon treatment in hairy cell leukemia]. Nordisk medicin, 1992, Volume: 107, Issue:3 Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin	1992
Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine. Proceedings of the National Academy of Sciences of the United States of America, 1992, Apr-01, Volume: 89, Issue:7 Topics: 2-Chloroadenosine; Adenine Nucleotides; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Cell Death; Cladribine; Clofarabine; Deoxyadenosines; DNA; DNA Damage; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Mice; Mice, SCID; Monocytes	1992
From the Food and Drug Administration. JAMA, 1992, May-13, Volume: 267, Issue:18 Topics: 2-Chloroadenosine; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Antitubercular Agents; Cladribine; Deoxyadenosines; Drugs, Investigational; Equipment and Supplies; Fetus; Humans; Leukemia, Hairy Cell; Mycobacterium avium-intracellulare Infection; Product Surveillance, Postmarketing; Rifabutin; Rifamycins; United States; United States Food and Drug Administration	1992
Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine. Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:5 Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Neoplasms	1992
Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia. The Medical letter on drugs and therapeutics, 1992, Sep-18, Volume: 34, Issue:879 Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine	1992
A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood, 1992, Nov-01, Volume: 80, Issue:9 Topics: Bone Marrow; Cladribine; Female; Follow-Up Studies; Gene Rearrangement; Hemoglobins; Humans; Immunophenotyping; Infusions, Intravenous; Leukemia, Hairy Cell; Leukocyte Count; Male; Middle Aged; Platelet Count	1992
Biological markers and minimal residual disease in hairy cell leukemia. Leukemia, 1992, Volume: 6 Suppl 4 Topics: Adult; Aged; Biomarkers; Bone Marrow; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Receptors, Interleukin-2; Tumor Necrosis Factor-alpha	1992
Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine. Acta haematologica Polonica, 1992, Volume: 23, Issue:4 Topics: Cladribine; Eosinophilia; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction	1992
[A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases]. Lakartidningen, 1991, Aug-28, Volume: 88, Issue:35 Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Lymphoproliferative Disorders	1991
2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes. Advances in experimental medicine and biology, 1991, Volume: 309A Topics: 2-Chloroadenosine; Cell Death; Cladribine; Deoxyadenosines; DNA; DNA Damage; Humans; In Vitro Techniques; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Nucleosomes; Reference Values	1991
A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity. Advances in experimental medicine and biology, 1991, Volume: 309A Topics: 2-Chloroadenosine; Acquired Immunodeficiency Syndrome; Antimetabolites, Antineoplastic; Cell Division; Cell Line; Cladribine; Cytotoxicity, Immunologic; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluorouracil; Humans; Interferon Type I; Killer Cells, Natural; Kinetics; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recombinant Proteins; Sarcoma, Kaposi; Uterine Cervical Neoplasms	1991
Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. The New England journal of medicine, 1990, Apr-19, Volume: 322, Issue:16 Topics: 2-Chloroadenosine; Adult; Antineoplastic Agents; Bone Marrow; Cladribine; Deoxyadenosines; Female; Humans; Infusions, Parenteral; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction	1990